hg_199220.1

Basic information about the TSS

---

TSS ID: hg_199220.1 Species: human Chr: chrX		Start: 48958371 End: 48958390 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000428668.2 Distance: 0 GeneID: 55593 HGNC/MGI_ID: HGNC:25402 UniProt_ID: Q96G74

Gene_name: OTU deubiquitinase 5 Gene_symbol: OTUD5 Gene_synonyms: DKFZp761A052 DUBA Gene_source: HGNC:25402

TATA-Box annotation

---

Distance to TSS:	0
Nearest PromoterID:	NM_001136159
Entrez ID:	55593
Nearest Unigene:	Hs.496098
Nearest Refseq:	NM_017602
Nearest Ensembl:	ENSG00000068308
Gene Name:	OTU deubiquitinase 5
Gene Alias:	DUBA
Gene Description:	OTU deubiquitinase 5
Gene Type:	protein-coding
CpG%:	0.055
GC%:	0.577114
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@OTUD5 p2@OTUD5 p3@OTUD5 p4@OTUD5 p5@OTUD5 p6@OTUD5 p7@OTUD5 p8@OTUD5 p10@OTUD5
Sample		p1@OTUD5	p2@OTUD5	p3@OTUD5	p4@OTUD5	p5@OTUD5	p6@OTUD5	p7@OTUD5	p8@OTUD5	p10@OTUD5
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	14.81	10.52	6.04	3.51	2.53	0.58	0.39	3.90	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	13.96	12.54	5.66	5.06	2.02	1.01	0.81	4.65	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	14.27	12.92	6.94	5.02	1.74	0.77	0.58	5.98	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	9.56	11.64	4.99	4.16	1.66	0.62	0.42	6.03	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	13.72	11.92	6.07	4.50	2.25	0.90	0.45	7.20	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	10.08	9.69	5.04	4.46	1.94	0.19	0.78	6.40	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	15.69	9.80	4.36	4.58	1.53	1.96	0.87	2.18	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	16.47	8.72	2.91	1.21	1.45	0.00	0.00	0.97	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	17.95	9.19	4.70	2.78	3.85	0.43	0.21	1.50	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	22.03	8.69	5.22	6.38	0.58	0.58	0.00	1.74	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	16.57	10.11	7.28	6.47	2.43	1.21	0.40	3.64	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	17.89	8.54	6.91	3.25	1.63	0.81	0.00	1.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	15.64	5.48	2.74	1.13	0.81	0.00	0.32	0.48	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	12.18	5.86	2.41	1.05	0.75	0.15	0.45	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	13.83	4.83	0.88	1.76	0.44	0.00	0.22	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	15.09	5.28	1.76	0.50	0.25	0.25	0.25	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	13.76	3.49	0.87	1.31	0.87	0.22	0.22	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	13.50	5.48	2.11	1.27	0.00	0.00	0.00	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	8.00	2.67	2.13	1.07	1.07	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	13.09	6.47	2.56	1.20	1.50	0.00	0.15	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	13.77	7.08	2.27	1.07	1.07	0.00	0.13	0.40	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	13.29	6.39	3.63	1.55	1.55	0.00	0.35	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	12.54	4.39	1.42	1.29	1.16	0.26	0.00	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	15.05	7.04	1.21	1.46	1.21	0.00	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	13.67	7.22	0.52	1.03	0.26	0.26	0.00	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	14.24	5.70	1.58	1.58	0.95	0.32	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	13.19	7.69	1.65	1.10	1.10	0.00	0.00	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	16.27	9.19	3.54	1.18	2.59	0.47	0.24	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	12.11	7.59	3.39	1.13	1.29	0.48	0.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	13.39	5.43	1.45	1.45	0.72	0.36	0.18	0.36	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	14.44	4.81	1.88	0.84	0.63	0.21	0.00	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	12.11	6.64	1.95	0.78	1.37	0.39	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	12.03	5.91	2.32	1.48	1.90	0.00	0.00	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	8.74	9.73	4.45	1.15	2.47	0.33	0.16	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	10.47	6.54	3.18	2.24	1.12	0.19	0.37	0.37	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	17.82	6.71	1.15	1.34	1.15	0.38	0.38	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	17.17	9.81	2.45	1.23	1.02	0.61	0.00	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	11.28	6.85	1.81	1.01	0.20	0.20	0.40	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	10.53	5.67	4.05	1.08	0.81	0.27	0.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	12.96	7.92	3.60	1.44	0.48	0.24	0.00	0.24	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	12.47	7.76	2.12	1.41	0.47	0.00	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	9.08	6.59	3.22	2.20	0.44	0.15	0.29	0.00	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	16.24	5.48	1.48	1.48	1.69	0.42	0.42	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	13.29	6.12	2.10	0.52	0.70	0.70	0.17	0.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	15.86	6.42	2.81	1.20	0.60	0.20	0.00	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	14.89	5.35	0.93	1.16	0.70	0.47	0.00	0.00	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	17.03	6.48	2.40	0.72	0.72	0.72	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	12.22	8.64	1.79	0.00	1.19	0.00	0.00	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	11.97	8.62	1.68	0.72	0.24	0.24	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	11.93	7.08	1.82	1.01	1.01	0.20	0.20	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	9.84	4.92	1.84	1.64	0.20	0.41	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	17.12	6.45	2.45	0.89	0.89	0.00	0.44	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	14.19	4.97	1.06	1.77	1.06	0.35	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	19.22	4.31	3.98	0.99	0.99	0.00	0.33	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	6.71	8.39	3.36	6.71	0.84	2.52	0.00	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	4.59	7.35	4.59	1.38	1.38	1.38	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	18.15	3.24	2.27	1.62	0.65	0.00	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	16.06	2.89	1.61	0.64	1.28	0.00	0.00	0.00	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	11.63	5.66	3.77	2.83	1.57	0.31	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	19.74	5.64	0.71	0.00	0.00	0.00	0.71	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	19.63	2.24	1.12	0.56	0.00	0.00	0.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	3.98	3.98	7.96	0.80	0.00	0.80	0.80	0.00	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	5.78	4.08	1.02	1.70	1.02	0.00	0.00	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	19.50	4.22	0.32	0.97	0.32	0.32	0.00	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	17.75	2.84	2.13	1.06	1.06	0.00	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	16.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	0.00	7.90	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	18.04	1.46	2.93	0.49	0.49	0.00	0.98	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	15.37	3.97	0.00	0.50	0.00	0.50	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	21.11	0.94	2.35	0.94	0.94	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	7.95	2.65	2.65	1.66	0.33	0.33	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	19.18	1.86	2.17	0.31	0.62	0.00	0.00	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	24.15	2.45	2.75	2.45	1.22	0.00	0.31	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	7.29	3.48	1.90	2.38	0.63	0.16	0.63	0.16	0.32
Adipocyte - breast, donor2	11327-117E4	7.06	3.69	3.21	1.93	1.28	0.16	0.32	0.00	0.16
Adipocyte - omental, donor1	11473-119C6	7.00	4.07	3.18	2.80	0.64	0.13	0.38	0.64	0.25
Adipocyte - omental, donor2	11474-119C7	5.98	2.99	1.49	4.48	0.00	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	7.37	2.68	3.35	1.00	1.67	0.00	0.00	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	8.29	1.91	3.19	0.00	0.00	0.00	0.00	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	6.60	3.30	4.40	2.20	4.40	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	8.58	3.16	0.45	2.26	1.35	0.45	0.00	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	8.86	2.78	4.17	4.52	1.74	0.00	0.70	0.17	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	8.02	1.76	1.96	1.56	1.17	0.20	0.20	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	10.30	3.09	3.35	0.77	0.51	0.26	0.00	0.51	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	11.43	3.35	1.67	0.84	1.12	0.84	0.84	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	6.47	2.94	1.76	1.18	2.35	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	5.31	2.33	3.14	1.85	1.29	0.24	0.32	0.00	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	6.13	2.90	3.23	1.29	1.29	0.00	0.32	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	6.40	3.20	3.73	0.53	1.07	0.00	0.00	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	8.35	2.78	1.67	1.11	1.67	1.11	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	2.91	3.74	2.91	2.08	0.83	0.42	0.00	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	5.78	1.26	3.27	1.00	1.00	0.00	0.00	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	3.60	1.64	3.60	2.62	1.96	0.00	0.33	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	3.35	0.61	4.26	0.61	0.91	0.30	0.30	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	23.20	3.76	3.54	0.66	0.88	0.66	0.00	0.44	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	15.42	2.51	1.43	0.72	1.08	1.08	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	7.19	3.59	7.19	0.00	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	4.86	3.60	2.16	2.16	0.36	0.00	0.00	0.18	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	5.02	0.00	6.69	3.35	1.67	0.00	0.00	1.67	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	9.86	5.75	3.08	4.73	0.82	0.00	0.21	0.21	0.41
Anulus Pulposus Cell, donor1	11248-116E6	15.79	5.61	5.84	3.78	2.06	0.00	0.80	0.00	0.34
Anulus Pulposus Cell, donor2	11463-119B5	13.22	6.12	5.39	0.98	1.71	0.00	0.49	0.49	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	4.94	3.59	2.70	0.45	1.35	0.00	0.90	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	9.55	3.04	6.95	1.74	0.43	0.00	0.00	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	0.00	2.14	0.00	0.00	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	10.16	1.49	3.59	1.20	0.90	0.00	0.00	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	7.59	1.26	2.53	5.06	3.79	2.53	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	10.56	1.98	3.30	3.30	1.32	0.00	0.00	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	9.10	3.90	2.27	1.30	0.65	0.00	0.00	0.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	6.31	3.40	3.40	2.91	0.97	0.49	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.31	1.19	1.78	1.78	1.19	0.00	0.00	0.59	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	8.29	4.90	2.64	1.51	1.13	0.38	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	13.06	6.53	2.18	0.00	0.73	0.00	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	3.76	0.00	0.00	0.00	1.25	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	6.42	4.78	1.98	0.99	0.33	0.00	0.33	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	8.19	5.46	0.00	5.46	1.36	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	8.90	3.47	1.21	0.75	0.45	0.60	0.00	0.30	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	9.11	4.82	5.36	1.61	1.07	0.00	0.00	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	9.82	4.16	3.02	1.13	0.76	0.00	0.38	0.19	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	8.02	3.21	1.07	1.07	0.80	0.27	0.00	0.80	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	5.85	5.85	3.90	1.95	0.00	0.00	0.98	0.00	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	10.95	4.64	3.65	1.16	0.83	0.17	0.00	0.17	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	14.41	3.60	1.20	1.20	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	10.46	4.80	2.06	1.03	0.86	0.34	0.17	0.17	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	10.19	5.83	3.40	1.94	1.46	0.97	0.49	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	10.25	5.69	1.90	3.42	1.52	1.14	0.38	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	12.11	3.63	3.63	0.00	0.00	0.00	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	11.97	6.84	3.99	2.28	0.00	0.57	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	8.98	5.56	2.99	0.86	0.86	0.00	0.21	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	10.07	3.61	2.06	1.55	0.26	0.00	0.26	0.52	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	8.91	1.88	1.41	0.47	0.94	0.47	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	9.32	6.43	4.18	0.64	0.00	0.00	0.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	9.27	2.85	3.57	2.14	0.00	0.00	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	11.11	3.51	2.34	1.75	0.58	0.00	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	9.33	3.61	3.31	1.20	0.90	0.00	0.00	0.60	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	3.56	5.94	1.19	3.56	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	9.15	4.07	2.03	3.05	1.02	0.51	0.00	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	8.15	2.80	2.04	1.02	1.02	0.25	0.25	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	15.25	3.18	1.27	1.91	0.64	0.00	0.64	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	6.90	3.45	5.18	0.86	1.29	0.00	0.00	0.86	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	7.83	4.87	3.60	1.48	0.64	0.21	0.00	0.42	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	8.12	4.06	3.19	1.16	0.29	0.00	0.00	0.87	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	8.50	3.78	0.94	3.78	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	8.82	3.90	2.20	2.03	0.85	0.17	0.00	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	2.32	6.95	2.32	4.63	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	6.34	2.11	2.11	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	10.94	3.22	2.79	1.29	0.86	0.00	0.43	0.00	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	8.42	3.01	2.41	0.60	1.20	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.10	5.10	2.19	0.73	0.00	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	11.03	5.29	2.76	1.38	0.69	0.92	0.00	0.23	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	5.10	5.10	2.55	0.00	0.00	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	9.41	2.29	2.54	1.78	0.00	0.25	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	8.26	5.57	3.72	0.83	1.03	0.00	0.41	0.41	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	12.24	2.14	1.22	2.75	0.92	0.31	0.00	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	10.52	4.78	3.82	1.91	0.48	0.00	0.96	1.43	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	11.31	4.66	3.55	1.77	1.77	0.22	0.44	0.67	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	4.58	3.05	1.53	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	9.97	2.77	6.09	2.22	0.00	0.55	0.00	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	9.53	4.77	1.59	1.32	0.79	0.53	0.00	0.26	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	7.27	2.18	2.91	3.27	0.00	0.36	0.00	0.73	0.00
Astrocyte - cerebellum, donor1	11500-119F6	13.39	3.68	3.44	0.49	2.09	0.37	0.12	0.12	0.25
Astrocyte - cerebellum, donor2	11580-120F5	15.23	2.23	4.45	0.68	2.05	0.17	0.17	0.00	0.17
Astrocyte - cerebellum, donor3	11661-122F5	15.94	3.57	4.19	2.31	0.84	0.42	0.42	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	13.94	4.18	2.44	1.74	1.05	0.35	0.70	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	23.13	2.91	3.72	1.13	0.97	0.49	0.32	0.00	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	17.45	2.24	2.68	0.89	2.39	0.15	0.45	0.15	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	15.83	8.26	5.05	0.57	1.61	0.57	0.23	0.46	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	18.17	7.39	3.38	0.00	1.13	0.00	0.50	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	17.52	5.92	3.30	0.57	0.80	0.46	0.23	0.11	0.11
Basophils, donor1	12241-129G9	10.46	17.26	16.74	11.51	0.52	7.85	0.00	3.40	0.78
Basophils, donor2	12242-129H1	22.37	11.55	8.66	4.69	0.00	8.66	0.00	0.00	1.44
Basophils, donor3	12243-129H2	13.38	10.14	8.82	5.73	0.59	3.53	0.59	0.88	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	6.04	7.11	2.16	1.51	1.08	0.00	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	11.43	5.94	1.83	0.00	1.37	0.00	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.28	0.63	1.26	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	10.81	2.50	0.83	0.62	0.21	0.21	0.00	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	11.28	1.38	4.15	0.23	0.69	0.00	0.23	0.23	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	6.30	9.54	1.62	1.26	1.62	0.36	0.36	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	15.77	8.14	3.19	1.13	0.62	0.00	0.00	0.62	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	19.33	6.29	2.10	0.23	1.40	0.00	0.00	0.23	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	13.43	9.59	5.12	2.24	1.60	0.00	0.64	0.32	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	10.34	10.34	10.34	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	5.07	15.22	10.71	8.45	0.56	4.51	1.13	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	8.91	8.91	11.14	2.60	1.11	3.71	0.19	1.30	0.74
CD14+ Monocytes, donor3	11381-118B4	8.78	10.54	11.85	7.03	0.88	2.63	0.22	0.88	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	6.23	8.21	4.81	2.55	1.70	0.00	0.00	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	6.44	4.55	3.03	1.14	0.76	0.38	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	8.88	7.23	7.23	2.63	5.59	0.00	0.66	0.00	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	7.08	16.19	5.20	4.77	1.73	0.29	0.29	1.01	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	5.43	11.47	3.92	4.83	1.51	1.21	0.91	2.72	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	5.21	13.50	6.40	5.92	0.71	0.95	0.71	2.84	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	6.19	8.20	4.18	5.69	0.50	0.84	0.33	1.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	6.07	6.90	3.04	3.31	0.00	1.38	0.55	1.93	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	3.72	7.19	5.70	3.97	0.99	0.99	0.25	2.23	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	5.29	8.22	4.50	4.31	0.98	2.55	0.39	1.17	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	4.45	6.77	4.99	1.96	0.18	1.42	0.36	1.42	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	6.53	10.45	5.22	5.01	0.00	4.13	0.44	2.39	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	6.56	7.02	5.38	2.58	0.70	0.47	0.23	1.87	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	10.03	6.34	8.98	1.58	0.53	0.53	0.00	2.64	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	4.44	8.87	1.11	3.33	0.00	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	4.16	8.78	4.91	3.57	1.34	0.59	0.15	1.64	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	3.99	8.78	3.99	3.19	0.60	2.20	0.40	1.40	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	2.50	9.79	3.75	5.20	1.25	2.08	0.21	2.08	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	4.35	13.50	4.12	5.03	1.14	1.14	0.69	2.29	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	3.62	7.69	1.81	5.20	0.23	3.39	0.23	2.49	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	6.11	10.48	6.11	3.49	1.31	6.55	1.31	3.93	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	6.72	11.03	6.46	2.42	0.27	0.27	0.00	1.08	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	7.50	15.35	5.06	1.74	1.05	0.70	0.00	1.74	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	3.79	11.78	7.15	3.79	0.00	0.84	0.00	4.21	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	5.88	8.63	4.59	2.76	0.00	0.73	0.00	0.73	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	2.82	5.64	4.23	3.52	0.70	1.41	0.35	1.06	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.07	4.83	5.26	2.63	0.44	1.75	0.00	1.32	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	4.88	12.55	4.53	3.49	0.52	1.92	0.00	1.74	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	3.72	8.92	4.46	4.46	0.00	1.49	0.37	0.37	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	3.88	11.21	7.11	5.82	1.08	3.02	0.65	1.51	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	5.73	8.60	6.14	3.69	0.00	2.05	0.00	1.64	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	3.71	7.19	3.48	2.32	0.70	3.25	0.23	0.93	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	2.55	8.58	4.64	3.25	0.46	1.16	0.00	0.93	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	3.27	10.68	6.10	2.62	0.65	1.74	0.44	2.83	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	5.77	11.09	8.08	4.85	0.92	1.15	0.92	1.85	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	3.47	8.66	4.77	3.03	0.65	0.65	0.22	1.52	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	5.45	16.51	7.47	4.36	1.71	0.93	0.16	1.25	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	4.37	14.84	7.68	3.14	1.05	0.35	0.52	1.05	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	4.46	9.59	6.91	2.90	1.11	0.67	0.00	1.11	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	3.32	14.29	6.12	6.89	1.28	1.02	1.02	3.06	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	4.83	11.64	7.90	4.39	1.76	1.10	0.66	2.63	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	4.42	7.58	7.58	5.05	1.05	0.21	0.84	1.89	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	26.42	16.26	8.13	0.00	2.03	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	29.83	18.31	4.07	2.71	3.39	0.68	0.00	2.03	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	32.10	23.82	8.28	4.14	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	36.78	25.05	6.93	6.93	0.00	0.00	0.00	1.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	28.41	20.37	11.79	0.54	2.14	0.54	0.00	1.07	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	27.38	16.14	8.42	4.91	2.11	0.70	0.00	1.40	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	22.75	18.82	7.84	0.00	0.78	0.00	0.00	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	21.09	26.37	9.23	1.32	1.32	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	40.27	27.12	17.26	4.93	0.82	9.86	0.00	4.93	0.00
CD19+ B Cells, donor2	11624-122B4	28.29	19.59	13.06	2.18	1.45	8.71	0.73	5.08	0.00
CD19+ B Cells, donor3	11705-123B4	33.82	18.17	12.12	5.55	0.00	7.07	0.00	3.53	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	10.51	88.49	25.05	24.65	5.66	33.13	2.02	2.02	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	16.78	75.10	13.18	21.57	2.80	22.37	2.00	2.40	1.60
CD34+ Progenitors, donor1	11545-120B6	11.04	9.04	7.03	2.01	0.00	0.00	1.00	2.01	0.00
CD34+ Progenitors, donor2	11625-122B5	9.55	7.30	11.80	1.69	1.69	3.93	1.69	1.69	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	10.15	8.64	3.76	1.13	2.63	0.38	0.38	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	6.99	7.89	5.41	1.35	2.93	0.45	0.45	0.23	0.23
CD4+ T Cells, donor1	11225-116C1	34.63	20.35	15.00	3.57	0.36	13.93	0.00	2.86	0.71
CD4+ T Cells, donor2	11306-117C1	33.68	28.17	15.92	1.22	0.61	12.25	2.45	4.29	0.00
CD4+ T Cells, donor3	11382-118B5	25.92	16.16	8.54	3.96	1.52	7.93	0.61	4.57	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	14.04	23.99	7.40	1.28	1.02	3.32	0.00	3.57	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	24.26	33.46	5.84	0.90	1.12	2.47	0.22	2.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	23.86	39.96	5.75	1.15	1.72	6.90	0.29	3.45	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	33.19	36.03	15.65	3.79	0.00	2.84	0.47	2.37	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	35.12	43.54	8.43	4.21	0.70	1.40	1.40	2.11	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	42.85	39.55	6.59	3.30	0.00	0.00	0.00	6.59	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	18.93	25.43	6.07	2.31	1.45	11.27	0.43	3.18	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	25.59	30.16	4.41	0.85	1.02	7.46	0.00	5.08	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	25.95	34.66	5.32	0.81	1.13	17.25	0.32	4.84	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	23.31	31.38	8.07	1.79	3.14	2.24	0.45	1.34	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	22.01	32.14	8.39	1.75	0.70	1.05	0.00	2.80	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	19.36	33.00	11.00	1.32	1.76	8.36	0.00	3.08	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	5.90	15.18	7.17	0.84	1.69	1.69	0.00	1.69	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	11.22	15.37	4.16	1.04	0.62	0.42	0.00	1.66	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	11.69	16.04	7.02	0.67	1.34	0.67	0.33	4.34	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	31.54	39.16	10.06	2.99	1.09	2.72	0.54	0.27	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	33.76	34.84	12.33	7.50	3.22	3.75	0.00	1.07	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	30.48	21.52	16.14	5.38	3.59	1.79	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	13.17	12.98	5.56	0.74	0.19	0.19	0.74	0.74	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	12.13	15.38	2.82	1.08	0.43	1.30	0.43	0.87	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	17.86	19.33	4.83	0.42	2.52	0.21	0.42	0.42	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	20.22	24.77	7.08	4.04	0.51	3.03	0.00	1.52	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	24.26	33.79	6.93	3.90	1.73	3.47	0.43	1.73	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	23.10	22.66	8.72	3.05	1.31	2.61	0.44	3.92	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	32.17	25.73	14.35	0.99	1.48	0.49	0.00	0.99	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	34.16	20.31	12.00	1.85	3.69	0.92	0.00	1.85	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	20.94	23.73	9.77	1.40	2.79	0.00	4.19	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	36.83	20.77	14.40	1.38	1.38	1.38	1.11	0.83	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	26.75	25.52	20.12	1.23	4.42	0.25	0.74	0.49	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	36.96	20.02	9.24	0.00	0.00	0.00	0.00	1.54	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	26.50	29.37	13.97	1.43	2.51	0.36	0.36	1.07	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	36.01	15.23	9.69	4.15	0.00	1.38	2.77	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	37.32	18.66	9.17	4.58	1.31	19.97	0.33	4.26	0.33
CD8+ T Cells, donor2	11307-117C2	43.93	22.15	16.14	4.13	2.25	15.77	1.13	3.38	0.00
CD8+ T Cells, donor3	11383-118B6	54.79	14.90	13.38	3.28	2.02	13.63	1.01	1.51	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	12.16	5.73	1.84	0.69	0.46	6.88	0.23	8.26	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	9.59	6.23	2.64	0.72	0.72	5.51	0.24	9.83	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	11.76	6.29	1.92	1.92	0.27	4.65	0.55	8.48	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	6.90	9.01	4.50	2.40	1.80	7.21	0.30	11.11	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	15.60	4.80	3.36	1.44	1.92	5.52	0.48	9.84	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	11.82	7.05	2.73	0.68	0.68	5.68	0.00	7.96	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	17.82	7.82	3.69	0.87	0.87	7.39	0.00	8.47	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	17.11	7.37	3.16	1.32	1.58	6.84	0.26	9.21	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	13.13	5.86	3.52	1.17	0.70	6.57	0.23	8.21	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	13.89	10.57	4.23	1.81	0.60	4.53	0.60	10.26	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	17.72	10.75	3.49	2.03	0.58	4.07	0.00	10.17	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	15.72	7.99	2.13	0.53	0.53	4.53	0.27	10.92	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	11.82	8.32	1.31	1.75	0.44	11.38	0.44	4.82	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	17.31	7.74	2.73	2.28	3.64	7.74	0.00	5.47	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	14.92	6.71	3.73	3.73	0.75	5.22	0.00	10.44	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	11.16	6.48	5.04	1.08	0.36	5.76	0.36	7.20	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	14.96	8.92	2.30	0.58	1.44	3.74	0.29	7.48	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	9.43	6.36	3.77	0.94	0.47	4.24	0.24	4.95	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	16.16	7.29	4.44	1.58	0.95	7.61	0.00	9.82	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	19.99	9.53	4.00	1.85	1.85	7.38	0.31	6.77	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	18.91	5.77	4.81	1.28	0.96	5.77	0.00	5.13	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	17.21	11.47	4.97	1.53	1.53	7.65	0.00	8.80	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	18.92	6.70	3.55	0.39	0.79	3.15	0.00	7.09	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	9.08	6.81	1.51	0.76	2.27	2.27	0.00	9.08	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	32.92	14.45	4.82	3.21	2.41	19.27	0.00	9.64	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	29.38	14.69	2.10	3.50	0.70	10.49	0.00	11.19	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	27.05	9.02	8.01	2.00	3.01	7.01	1.00	6.01	0.00
Cardiac Myocyte, donor1	11525-119I4	5.48	9.14	3.66	1.83	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	13.34	5.43	4.94	0.99	0.99	0.99	0.00	1.48	0.00
Cardiac Myocyte, donor3	11686-122I3	10.31	4.84	2.95	2.42	1.05	0.00	0.11	0.11	0.11
Chondrocyte - de diff, donor1	11261-116G1	7.28	4.85	3.12	1.04	1.73	0.35	0.00	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	10.31	1.78	2.84	2.49	0.71	0.36	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	8.31	4.32	2.16	2.62	0.80	0.00	0.68	0.23	0.11
Chondrocyte - re diff, donor2	11339-117F7	5.37	1.79	0.00	4.48	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	10.92	1.62	2.83	4.04	0.00	0.00	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	14.57	4.48	2.52	2.18	1.03	0.34	0.34	0.23	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	14.32	3.21	2.57	1.28	0.86	0.00	0.21	0.00	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	14.69	5.13	3.54	2.04	1.06	0.18	0.18	0.09	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	18.89	6.97	9.72	5.23	2.02	0.18	0.92	0.18	0.28
Corneal Epithelial Cells, donor1	11526-119I5	17.13	4.17	1.54	1.10	0.66	0.00	0.00	0.22	0.22
Corneal Epithelial Cells, donor2	11606-120I4	7.96	6.83	3.41	1.14	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	12.01	5.11	1.28	0.26	0.77	0.26	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	8.58	5.78	2.48	0.66	0.33	0.00	0.50	0.33	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	8.52	5.99	1.89	1.58	0.32	0.00	0.00	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	6.90	3.45	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	7.99	4.86	3.78	1.94	0.54	0.22	0.00	0.54	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	25.62	16.40	7.86	3.76	0.34	10.59	0.68	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	20.89	12.40	5.88	7.83	0.65	15.02	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	22.75	16.45	11.13	2.90	0.00	10.16	0.48	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	11.84	1.00	2.17	1.17	0.50	0.17	0.00	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	14.08	1.76	3.52	2.35	0.59	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	12.16	2.83	1.13	2.55	1.13	0.28	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	10.62	2.75	1.97	1.57	0.39	0.39	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	10.76	4.07	1.75	0.87	2.33	0.00	0.00	0.87	0.00
Endothelial Cells - Artery, donor2	11341-117F9	17.41	5.18	3.29	2.35	2.12	0.00	0.24	0.47	0.00
Endothelial Cells - Artery, donor3	11413-118E9	16.13	2.10	3.33	1.23	0.53	0.18	0.53	0.70	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	8.20	3.32	1.55	2.44	0.66	0.22	0.00	0.00	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	7.91	3.04	0.91	1.83	0.91	0.00	0.00	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	4.23	3.66	1.69	1.97	0.00	0.00	0.56	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	10.40	7.73	3.86	0.59	0.30	0.00	0.00	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	8.85	2.60	1.56	1.56	0.00	0.00	0.00	0.52	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	11.34	7.23	2.84	1.70	1.99	0.00	0.00	0.85	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	6.00	3.60	3.20	0.00	1.60	0.00	0.00	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	12.58	6.81	1.57	1.05	1.05	0.00	0.00	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	15.03	3.48	2.61	0.99	1.62	0.12	0.12	0.62	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	6.30	1.96	0.65	1.09	0.43	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	7.21	1.71	2.32	1.22	0.61	0.49	0.24	0.24	0.12
Endothelial Cells - Vein, donor1	11267-116G7	21.61	1.14	2.28	2.28	0.00	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	10.48	1.40	2.10	2.10	0.70	1.40	0.00	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	18.53	1.73	1.73	0.94	0.94	0.79	0.00	0.00	0.16
Eosinophils, donor1	12244-129H3	15.25	30.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	4.95	184.83	56.11	41.26	0.00	46.21	3.30	33.01	0.00
Eosinophils, donor3	12246-129H5	0.00	160.51	39.24	28.53	3.57	32.10	0.00	28.53	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	10.02	3.42	1.95	0.49	0.24	0.49	0.00	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	2.08	2.08	0.00	0.00	0.00	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	12.73	2.87	2.87	1.64	0.82	0.00	0.00	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5.36	4.49	1.97	1.53	0.77	0.00	0.44	0.33	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	10.08	2.60	2.06	1.84	1.19	0.22	0.65	0.33	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	10.19	3.64	4.97	3.64	0.49	0.24	0.73	0.12	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	10.51	10.10	4.78	2.59	2.05	0.27	0.82	0.41	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	9.28	5.70	3.16	2.64	0.84	0.32	0.42	0.00	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	9.75	6.85	5.53	0.79	3.43	0.26	1.05	0.79	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	10.96	1.99	4.32	1.66	1.66	0.00	0.66	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	15.88	4.99	3.63	1.81	1.81	0.00	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	12.89	5.31	4.55	3.79	0.00	0.00	0.00	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	7.89	5.05	2.84	2.05	1.89	0.00	0.32	0.63	0.00
Fibroblast - Cardiac, donor4	11452-119A3	10.91	2.42	2.73	0.61	0.61	0.00	0.30	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	7.23	2.66	2.28	2.16	0.63	0.25	0.00	0.13	0.38
Fibroblast - Cardiac, donor6	11460-119B2	8.03	1.36	2.88	0.76	0.45	0.30	0.45	0.15	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	8.98	3.22	6.83	1.88	1.88	0.13	0.40	0.54	0.67
Fibroblast - Choroid Plexus, donor2	11572-120E6	7.77	4.31	3.45	2.16	1.29	0.00	0.00	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	16.11	1.46	4.39	0.00	1.46	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	26.98	2.77	4.61	1.38	1.61	0.23	0.69	0.23	0.92
Fibroblast - Conjunctival, donor3	11692-122I9	15.60	6.11	4.92	3.56	1.02	0.00	0.34	0.00	0.17
Fibroblast - Dermal, donor1	11269-116G9	11.03	4.70	3.76	0.70	1.64	0.23	0.23	0.23	0.23
Fibroblast - Dermal, donor2	11346-117G5	15.57	0.47	1.42	2.36	0.00	0.47	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	10.76	5.20	2.90	1.93	1.21	0.12	0.12	0.24	0.12
Fibroblast - Dermal, donor4	11450-119A1	12.10	1.02	1.36	0.34	1.02	0.23	0.00	0.00	0.11
Fibroblast - Dermal, donor5	11454-119A5	10.64	0.35	2.44	0.35	0.70	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	11.37	0.49	1.79	0.65	1.14	0.00	0.00	0.16	0.49
Fibroblast - Gingival, donor1	11237-116D4	6.87	2.92	2.71	0.62	1.46	0.00	0.42	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	11.27	2.62	5.24	2.10	2.62	0.26	0.26	0.26	0.00
Fibroblast - Gingival, donor2	11318-117D4	10.15	1.32	1.71	0.66	0.92	0.40	0.00	0.00	0.00
Fibroblast - Gingival, donor3	11394-118C8	8.61	1.84	2.71	1.74	1.84	0.10	0.39	0.00	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	10.39	2.08	2.08	1.04	1.04	0.00	1.04	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	12.69	3.88	2.82	1.06	0.70	0.35	0.35	0.00	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	14.03	2.34	2.65	0.94	0.78	0.31	0.31	0.16	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	12.31	2.30	2.84	0.68	0.68	0.41	0.27	0.14	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	13.76	2.82	4.94	1.76	0.71	0.00	0.35	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	13.31	2.63	5.12	1.46	1.46	0.29	0.29	0.00	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	9.54	3.95	4.64	1.36	0.95	0.41	0.55	0.14	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	14.37	1.54	3.07	0.99	0.88	0.22	0.11	0.22	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	13.06	7.04	5.14	2.05	2.79	0.29	0.88	0.29	0.29
Fibroblast - Lung, donor1	11270-116H1	20.39	2.72	2.72	2.72	1.36	0.00	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	13.43	4.48	8.95	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	18.78	2.95	1.69	1.06	1.90	0.00	0.21	0.42	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	14.16	2.50	5.83	0.83	5.00	1.67	0.00	0.83	2.50
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	2.80	1.40	2.80	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	8.40	3.08	2.24	2.24	1.12	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	12.99	3.25	2.84	0.81	1.62	0.00	0.00	0.00	0.81
Fibroblast - Mammary, donor2	11620-122A9	0.00	3.99	3.99	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	11.91	5.96	5.96	0.00	0.00	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	12.80	1.75	2.72	0.39	0.19	0.00	0.39	0.19	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	11.53	1.21	1.82	0.46	0.91	0.15	0.30	0.00	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	8.26	0.61	1.53	0.61	0.00	0.31	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	8.78	1.53	3.82	0.76	1.53	0.00	0.76	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	13.50	3.78	4.32	0.81	0.27	0.54	0.54	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	9.16	3.83	2.44	2.67	1.39	0.23	0.23	0.12	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	9.40	3.54	2.76	1.99	1.11	0.22	0.22	0.00	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	18.49	1.83	3.66	0.41	1.02	0.81	0.20	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	14.03	2.67	4.68	0.00	0.67	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	11.47	4.35	2.37	1.98	1.58	0.00	0.00	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	15.68	6.55	8.14	2.98	1.59	0.20	0.20	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	8.17	2.66	2.13	3.55	1.42	0.18	0.71	0.18	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	8.47	2.17	2.56	2.17	1.77	0.00	0.39	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	14.14	7.22	6.92	2.11	3.31	0.00	0.60	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	9.61	3.99	2.70	1.73	1.84	0.00	0.22	0.00	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	17.46	8.86	12.65	2.02	2.78	0.25	0.76	0.00	0.76
Fibroblast - skin normal, donor1	11553-120C5	12.14	2.95	3.77	1.97	0.98	0.16	0.16	0.00	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	18.85	7.42	4.41	2.01	1.60	0.20	0.80	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	9.74	4.32	4.72	1.91	1.11	0.20	0.40	0.10	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	20.85	9.67	9.37	1.51	4.23	0.30	0.30	0.30	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	10.27	3.73	2.24	2.40	1.57	0.50	0.33	0.08	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	6.33	4.62	5.47	1.54	1.71	0.68	0.17	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	17.41	4.93	7.55	3.28	4.60	0.00	0.33	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	9.48	3.41	3.83	0.85	0.64	0.53	0.43	0.11	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	8.43	1.69	2.53	1.52	1.18	0.00	0.34	0.00	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	7.84	5.49	6.59	3.92	0.94	0.16	0.31	0.31	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	22.16	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	6.97	6.97	3.49	0.87	1.74	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	7.28	3.99	1.56	0.69	0.17	0.35	0.00	0.17	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	8.59	3.64	1.56	1.30	1.04	0.26	0.00	0.52	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	8.69	6.39	1.28	1.28	0.51	0.00	0.00	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	22.97	3.06	3.83	0.77	2.30	0.00	0.00	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	28.08	3.83	1.91	0.00	1.28	0.00	0.64	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	19.68	7.13	2.85	1.14	2.28	0.29	0.29	0.57	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	23.44	5.52	8.82	0.83	4.41	0.00	0.28	0.55	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	20.32	3.88	3.88	0.91	1.83	0.23	0.46	1.14	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	19.81	3.57	4.56	0.79	1.78	0.00	0.00	0.20	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	21.41	9.25	8.46	1.06	4.23	0.26	0.26	0.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	22.50	4.24	4.24	1.30	3.26	0.00	0.33	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	19.90	5.75	4.42	0.44	1.77	0.00	1.33	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	34.34	6.92	5.09	1.98	3.39	0.42	0.00	0.28	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	30.91	8.99	4.93	1.72	3.94	0.25	0.37	0.74	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	42.98	7.79	3.76	0.81	3.49	0.54	0.00	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	36.42	4.83	3.47	0.99	2.23	0.25	0.00	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	28.93	4.98	4.84	1.38	2.35	0.28	0.28	0.42	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	36.59	7.73	3.46	1.22	1.63	0.81	0.61	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	33.77	8.67	5.02	1.37	4.11	0.68	0.68	0.46	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	32.14	8.60	4.86	1.87	3.36	0.50	0.37	0.62	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	32.35	9.18	4.59	0.66	3.93	0.22	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	29.84	6.50	5.02	2.36	2.36	0.00	0.30	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	33.38	7.47	5.56	1.59	2.70	0.00	0.48	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	31.06	8.27	2.01	2.23	2.68	0.00	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	33.07	5.04	6.05	2.22	2.82	0.20	0.60	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	30.71	7.12	5.77	1.53	4.24	0.34	0.00	0.00	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	32.63	8.78	4.34	1.60	2.22	0.09	0.44	0.62	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	21.02	7.28	5.51	1.98	3.23	0.10	0.42	0.31	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	18.79	6.49	4.95	1.88	3.24	0.34	0.00	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	24.68	7.08	6.86	2.66	3.87	0.00	1.00	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	30.28	7.57	4.58	2.33	2.25	0.17	0.50	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	27.16	5.10	4.29	2.04	1.02	0.20	0.20	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	32.39	5.16	4.75	1.65	4.33	0.21	0.00	1.03	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	28.82	6.69	5.88	2.19	3.69	0.00	1.15	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	32.35	7.67	6.00	1.67	3.00	0.17	0.67	0.50	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	29.76	5.29	6.39	1.98	3.09	0.00	0.88	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	28.78	9.35	7.87	4.43	4.92	0.25	0.37	0.00	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	31.93	7.29	4.21	1.46	2.43	0.00	0.97	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	30.15	8.66	5.45	0.96	3.21	0.32	0.32	0.64	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	24.26	5.50	7.58	2.37	3.79	0.00	0.76	0.19	0.47
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	25.78	7.91	5.54	1.11	3.64	0.32	0.16	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	26.76	6.39	5.78	3.04	3.65	0.00	1.52	0.30	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	29.69	6.38	4.50	1.88	1.88	0.00	0.42	0.21	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	18.22	7.68	6.81	1.98	3.73	0.44	0.66	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	28.34	5.89	6.45	2.52	3.65	0.28	0.28	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	21.30	6.11	4.07	1.85	2.22	0.19	0.56	0.00	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	26.21	8.02	3.21	0.80	2.14	0.00	0.27	0.80	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	31.21	6.12	4.28	1.68	1.99	0.31	0.46	0.31	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	25.39	6.61	5.57	2.98	2.20	0.26	0.13	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	27.11	9.76	5.15	2.17	5.96	0.00	0.00	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	19.36	12.35	4.98	1.84	2.40	0.00	0.37	0.00	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	27.85	8.55	5.70	1.75	3.73	0.00	0.00	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	29.75	12.89	5.95	0.00	1.98	0.00	0.00	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	31.26	6.73	4.35	1.58	2.24	0.13	0.66	0.13	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	30.26	6.25	5.65	2.62	2.42	0.40	0.40	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	25.42	4.83	2.03	1.78	1.27	0.00	0.00	0.25	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	30.26	6.77	4.78	0.80	2.39	0.20	0.60	0.60	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	35.90	11.25	3.70	0.92	3.24	0.46	0.31	0.62	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	48.28	9.82	4.30	0.82	3.48	0.20	1.23	0.00	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	21.28	2.82	1.88	0.31	0.00	0.31	0.31	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	18.65	2.54	0.85	0.00	0.28	0.00	0.57	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	13.37	2.77	1.38	0.00	0.92	0.46	0.46	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	14.85	2.47	4.95	0.00	2.47	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	11.22	3.48	3.48	1.16	2.32	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	6.42	4.81	1.60	0.00	0.00	1.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	19.13	3.48	6.96	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	20.18	6.51	4.56	0.98	0.65	0.00	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	19.77	4.53	4.53	1.65	1.65	0.00	0.41	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	16.66	10.00	3.33	0.00	3.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	15.66	4.19	5.59	0.56	0.56	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	18.63	3.60	2.29	0.65	1.31	0.33	0.00	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	17.62	2.52	7.55	0.84	0.84	0.84	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	18.45	4.45	4.13	1.27	0.64	0.00	0.00	0.32	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	15.62	4.42	4.42	2.38	2.38	0.00	0.34	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	18.79	4.18	2.09	0.00	2.09	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	22.91	3.44	5.73	1.72	1.72	0.57	0.00	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	13.91	5.03	4.44	0.30	1.78	0.00	0.00	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	10.16	3.39	3.39	0.00	3.39	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	19.05	3.73	3.31	2.49	2.90	0.00	0.83	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	15.65	5.29	4.37	1.38	1.15	0.00	0.00	0.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	17.30	6.15	5.00	0.00	1.92	0.00	0.38	0.38	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	10.43	4.89	4.24	0.98	0.65	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	21.40	2.68	2.01	2.01	0.67	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	20.42	4.24	4.62	1.16	0.39	0.00	0.00	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	28.76	3.77	3.77	2.05	2.05	0.68	0.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	22.36	4.97	4.97	7.45	2.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	14.16	5.19	3.30	1.89	1.42	0.00	0.47	0.47	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	13.88	2.41	4.22	0.60	2.41	0.60	1.21	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	15.26	3.05	4.07	2.54	2.03	0.51	0.51	0.51	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	14.36	1.60	3.19	1.60	1.99	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	12.83	4.93	6.41	0.99	2.47	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	23.61	8.26	2.36	1.18	1.18	0.00	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	15.17	5.25	2.92	2.92	2.92	0.00	0.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	16.68	3.95	4.39	1.32	0.44	0.00	0.44	0.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	13.56	6.78	5.93	2.54	1.70	0.00	0.00	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	11.34	3.58	2.98	1.19	1.19	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	12.13	4.85	4.85	2.43	0.97	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	13.70	4.57	1.14	2.28	1.14	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	9.15	3.33	4.99	1.66	1.25	0.42	0.83	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	13.49	3.37	1.12	1.12	0.00	0.00	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	9.20	6.66	4.12	2.85	2.22	0.00	0.63	0.95	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	7.52	9.19	5.01	1.67	0.42	0.00	0.00	1.25	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	14.39	5.22	4.18	1.51	2.67	0.35	0.23	1.16	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	16.37	7.43	4.73	1.35	2.87	0.00	0.17	0.17	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	18.66	4.32	4.10	0.68	1.59	0.00	0.46	0.23	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	14.32	8.96	3.50	1.20	1.42	0.55	0.44	0.66	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	18.27	6.45	4.30	1.72	1.50	0.21	0.00	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	12.92	3.66	3.01	1.72	2.15	0.43	0.22	0.86	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	14.45	4.48	3.61	0.50	1.12	0.00	0.50	0.87	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	12.87	4.97	5.66	1.89	1.54	0.17	0.00	1.03	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	17.30	3.52	5.13	1.28	0.96	0.32	0.00	0.96	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	7.83	2.24	1.12	0.00	2.80	0.00	0.00	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	13.85	1.73	4.33	0.87	0.87	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	10.58	5.29	2.64	0.00	2.64	2.64	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	10.93	3.88	2.47	0.71	1.06	0.71	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	14.53	5.81	5.09	2.18	1.45	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	11.36	2.80	2.62	1.57	0.52	0.17	0.00	0.35	0.00
Hepatocyte, donor1	11523-119I2	3.63	14.53	13.32	6.05	0.00	1.21	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	6.46	12.93	5.39	3.23	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	3.07	6.14	6.14	5.52	1.23	0.00	0.00	1.23	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	20.23	2.61	7.83	0.65	1.96	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	7.52	5.07	2.62	2.27	0.35	0.17	0.52	0.70	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	13.86	4.39	2.74	1.37	1.23	0.00	0.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	57.31	28.66	3.18	6.37	3.18	0.00	0.00	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	26.70	6.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	45.68	18.00	12.46	1.38	4.15	0.00	0.00	4.15	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	25.03	17.52	17.52	7.51	7.51	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	47.47	0.00	0.00	11.87	0.00	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	38.44	25.63	10.25	2.56	12.81	0.00	0.00	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	59.42	36.57	9.14	0.00	13.71	0.00	0.00	9.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	51.98	47.11	11.37	1.62	8.12	0.00	0.00	4.87	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	43.35	21.67	8.34	5.00	1.67	0.00	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	25.41	7.26	7.26	3.63	0.00	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	56.91	37.06	10.59	1.32	5.29	1.32	0.00	3.97	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	36.59	27.72	5.54	3.33	2.22	0.00	0.00	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	47.14	20.95	10.48	5.24	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	33.38	25.82	6.93	0.63	2.52	0.00	0.00	1.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	32.48	15.47	4.64	3.09	0.00	0.00	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	43.90	14.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	34.24	34.89	10.34	4.52	4.52	0.00	0.00	3.88	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	43.47	19.32	12.88	3.22	11.27	1.61	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	35.84	11.95	0.00	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	41.56	27.71	12.22	4.07	4.07	0.00	0.00	4.89	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	38.20	28.13	4.62	3.36	2.10	0.00	0.42	2.52	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	14.37	0.00	0.00	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	35.36	35.36	7.23	5.63	7.23	0.00	0.00	2.41	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	37.85	18.47	5.54	0.00	1.85	0.92	0.00	3.69	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	15.08	30.16	15.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	30.68	21.71	4.25	3.78	1.42	0.00	0.47	2.83	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	43.54	10.88	5.44	2.72	0.91	0.00	0.00	1.81	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	44.23	14.74	0.00	0.00	0.00	0.00	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	35.51	27.98	6.46	2.15	2.15	0.00	1.08	3.23	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	54.63	21.60	6.35	3.81	5.08	0.00	0.00	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	49.29	16.43	0.00	0.00	0.00	0.00	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	30.61	22.32	7.01	0.64	1.91	0.00	0.00	2.55	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	54.68	18.23	10.94	5.47	1.82	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	94.83	31.61	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	33.56	17.85	8.57	4.28	1.43	0.00	0.00	3.57	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	53.09	26.55	9.95	0.00	6.64	0.00	0.00	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	26.54	14.20	4.32	2.78	2.47	0.62	0.31	1.23	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	36.88	17.56	7.02	5.27	3.51	0.00	0.00	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	66.01	15.72	6.29	0.00	3.14	0.00	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	45.20	22.95	3.48	4.17	2.09	0.00	0.00	1.39	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	28.77	17.70	17.70	4.43	4.43	0.00	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	51.87	32.42	16.21	3.24	0.00	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	34.01	28.77	4.36	3.49	3.49	0.00	0.00	2.62	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	27.00	24.75	11.25	0.00	11.25	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	31.36	17.42	0.00	3.48	0.00	0.00	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	22.40	32.00	8.53	7.47	5.33	1.07	0.00	2.13	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	34.64	23.55	6.93	1.39	2.77	0.00	0.00	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	37.04	28.50	11.40	0.00	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	33.14	14.73	7.36	6.44	3.68	0.00	0.00	2.76	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	21.18	27.23	24.20	0.00	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	24.83	6.21	6.21	12.42	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	24.32	25.38	14.80	7.40	6.34	0.00	1.06	2.11	1.06
Keratinocyte - epidermal, donor1	11272-116H3	11.18	7.43	2.94	1.06	0.49	0.16	0.16	0.49	0.16
Keratinocyte - epidermal, donor2	11349-117G8	12.30	1.17	0.00	2.34	0.59	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	12.87	3.22	2.27	1.14	0.85	0.19	0.09	0.28	0.00
Keratinocyte - oral, donor1	11251-116E9	12.94	7.15	1.70	1.25	1.70	0.11	0.34	0.11	0.57
Keratocytes, donor1	11527-119I6	25.44	1.03	3.44	1.72	0.69	0.00	1.03	0.00	0.00
Keratocytes, donor2	11607-120I5	4.69	2.34	2.34	0.00	1.17	0.00	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	10.67	2.17	3.75	1.19	1.98	0.00	0.20	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	4.40	4.40	15.39	4.40	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	30.20	3.24	3.24	2.16	1.08	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	16.38	4.38	2.77	1.27	2.19	0.12	0.35	0.00	0.12
Lens Epithelial Cells, donor3	11690-122I7	11.10	6.66	3.23	1.51	1.51	0.00	0.40	0.30	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	12.45	4.39	1.66	0.95	0.95	0.00	0.36	0.24	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	10.88	1.67	2.79	0.84	0.28	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	7.87	4.09	2.36	2.36	0.31	0.00	0.31	0.47	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	4.30	5.91	0.54	1.08	0.54	0.00	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	7.88	2.21	2.52	0.32	1.26	0.32	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	9.27	3.67	1.83	1.62	1.08	0.11	0.11	0.43	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	5.75	2.46	2.05	0.41	0.82	0.00	0.82	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	7.08	4.55	2.78	0.76	1.01	0.25	0.00	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	9.15	3.52	2.39	0.56	0.28	0.00	0.00	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	3.96	3.16	2.37	0.40	0.40	0.00	0.00	0.79	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	8.34	2.91	1.36	2.13	0.39	0.78	0.00	0.00	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	9.81	2.96	1.67	1.30	0.37	0.37	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	8.01	4.53	2.44	1.05	1.05	0.00	0.70	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	7.16	3.58	1.67	0.95	0.72	0.00	0.00	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	8.52	3.71	1.51	0.96	0.69	0.27	0.55	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	5.85	2.16	1.54	0.31	0.92	0.00	0.31	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	7.17	2.49	0.62	0.62	1.25	0.00	0.62	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	11.53	5.49	1.83	0.91	0.73	0.00	0.18	0.73	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	8.56	2.30	2.63	0.66	0.33	0.33	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	10.25	3.81	1.46	0.88	0.29	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	9.96	2.49	2.24	1.24	1.00	0.00	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	8.73	3.39	1.94	0.97	0.48	0.00	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	5.92	5.12	2.15	0.81	0.27	0.00	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	9.69	3.48	1.21	1.36	0.30	0.00	0.15	0.45	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	8.29	2.59	1.56	1.04	0.52	0.52	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	5.86	3.98	2.30	1.26	0.84	0.21	0.21	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	8.42	2.86	1.80	1.65	0.60	0.00	0.00	0.30	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	5.50	2.75	0.69	0.69	0.69	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	5.64	2.63	2.82	0.56	1.13	0.00	0.19	0.38	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	10.71	4.45	1.91	1.59	0.64	0.32	0.21	0.21	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	9.69	3.39	1.45	0.97	0.48	0.48	0.00	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	6.28	2.65	0.66	1.32	0.33	0.00	0.00	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	10.78	2.85	1.86	1.36	0.99	0.12	0.00	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	9.26	2.59	1.85	0.74	0.74	0.00	0.00	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	7.91	1.98	1.24	1.48	0.25	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	9.21	4.40	2.06	0.82	0.55	0.14	0.14	0.27	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	8.04	4.82	2.25	1.61	0.96	0.00	0.00	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	7.00	4.26	3.65	0.61	0.00	0.30	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	7.56	3.92	3.08	0.56	1.12	0.14	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	6.76	2.49	1.07	2.13	0.36	0.00	0.00	0.36	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	6.30	2.42	1.94	0.48	0.00	0.00	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	10.89	5.29	2.33	1.24	1.56	0.31	0.00	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	6.09	2.86	1.43	1.07	0.36	0.00	0.36	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	4.25	5.23	1.96	0.98	1.63	0.33	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	9.65	3.53	1.88	0.71	0.24	0.00	0.00	0.71	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	11.26	4.70	1.61	1.61	0.87	0.12	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	10.50	4.10	1.28	0.26	0.77	0.00	0.00	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.65	4.77	2.69	1.79	0.00	0.60	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	0.00	11.33	4.53	0.00	2.27	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	4.60	5.37	11.51	1.53	1.53	0.77	0.00	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	5.94	10.39	10.39	1.48	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	11.00	10.16	8.04	2.12	1.27	0.00	0.00	2.12	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	6.33	6.33	7.74	0.00	1.41	0.70	0.00	1.41	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	9.34	2.80	11.21	2.80	0.93	0.00	0.00	0.93	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	4.64	5.15	6.70	3.09	1.03	0.00	0.52	1.55	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	9.52	14.27	8.33	0.00	1.19	0.00	1.19	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	5.88	7.01	5.65	2.26	1.81	0.00	0.90	1.81	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	5.82	7.56	4.94	1.45	0.87	0.29	0.00	1.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	10.35	8.10	5.40	2.25	0.45	0.00	0.45	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	10.84	8.54	7.18	2.71	0.68	0.27	0.14	1.35	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	5.65	9.24	8.73	2.57	0.00	0.51	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	10.23	5.65	5.29	2.47	2.12	0.00	0.00	1.76	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	3.33	5.33	7.33	0.67	0.00	0.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	4.08	5.60	5.60	1.53	0.51	0.00	0.51	2.04	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	7.47	6.40	6.40	1.60	1.60	0.27	0.27	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	7.37	5.86	6.42	1.89	1.51	0.57	0.38	0.76	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	5.52	9.82	7.98	0.00	2.45	0.00	0.00	1.84	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	5.71	11.42	8.15	1.63	1.63	0.82	0.00	1.63	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	7.08	5.83	6.66	2.29	1.46	0.00	0.42	0.83	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	6.45	5.61	5.89	0.84	0.84	0.56	1.12	1.96	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	5.15	3.09	10.30	1.03	1.03	0.00	0.00	2.06	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	9.58	8.42	5.81	2.90	0.87	0.58	0.00	1.74	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	7.47	5.38	3.59	1.49	0.60	0.90	0.00	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	5.53	3.87	4.43	3.32	1.11	0.55	0.55	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	7.78	9.54	8.48	2.12	1.77	0.71	0.35	1.77	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	8.85	5.16	3.69	0.37	0.37	0.00	0.37	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	10.36	4.61	12.66	1.15	2.30	0.00	1.15	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	10.75	7.68	8.83	1.54	2.69	0.00	0.00	1.54	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	8.49	9.06	6.79	2.83	1.13	0.00	0.00	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	8.20	4.10	9.85	0.82	0.82	0.00	0.82	2.46	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	6.33	7.68	3.62	0.90	1.36	0.45	0.45	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	7.90	3.59	2.15	0.72	0.72	0.00	0.00	1.44	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	9.71	9.71	6.72	0.75	0.75	0.75	0.00	0.75	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	7.43	11.15	10.03	1.86	1.49	0.00	0.74	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	9.48	8.18	5.60	0.86	0.43	0.00	0.00	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	8.56	6.85	9.42	2.57	1.71	0.86	0.86	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	10.66	9.00	9.33	1.33	2.33	0.33	0.00	1.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	7.84	9.05	5.43	1.21	0.60	0.60	1.21	1.21	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	13.51	13.51	7.11	2.13	0.71	0.71	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	7.56	9.62	5.50	1.72	2.06	0.69	0.00	1.37	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	9.66	7.51	4.29	0.00	1.07	0.00	0.54	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	8.08	5.39	2.02	1.35	1.35	0.00	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	8.52	10.37	6.30	1.48	2.96	0.37	0.00	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	12.79	4.65	4.65	2.33	2.33	0.00	2.33	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	7.40	4.23	3.17	0.00	2.12	0.00	0.00	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	9.20	7.60	6.80	2.40	1.20	0.00	0.00	1.60	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	5.81	7.27	10.18	0.73	1.45	0.00	0.73	1.45	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	9.96	10.73	4.60	3.07	1.53	0.77	0.00	3.07	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	2.96	9.87	7.40	1.97	1.48	0.99	0.00	0.99	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	0.94	9.41	4.70	1.88	0.00	1.88	0.00	2.82	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	5.53	11.06	5.53	0.50	0.50	0.50	0.50	1.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	9.01	5.86	7.66	1.80	0.45	0.45	0.00	0.90	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	0.00	8.61	6.88	3.44	0.00	0.00	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	8.02	8.02	8.46	2.23	2.67	0.00	0.89	2.23	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	7.82	13.29	6.65	4.30	3.13	0.39	0.00	1.96	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	8.58	5.28	8.58	1.32	1.98	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	9.86	6.75	6.75	1.04	1.56	0.52	0.52	1.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	9.63	14.00	11.38	2.63	3.06	1.31	0.00	1.75	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	6.71	5.03	5.03	1.12	1.12	0.56	0.00	1.68	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	9.27	4.86	7.07	0.88	0.88	1.32	0.44	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	8.10	6.94	5.01	4.63	1.16	0.00	0.00	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	6.58	5.06	8.10	1.01	0.51	0.51	0.00	1.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	7.69	7.21	6.25	1.92	2.40	0.00	0.00	0.96	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	9.54	8.75	7.55	1.59	1.59	0.00	0.40	1.19	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	6.08	5.47	4.86	1.22	0.61	0.00	0.61	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	8.30	6.23	5.53	0.69	0.00	0.69	0.00	3.46	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	9.88	6.08	4.94	1.90	1.14	0.00	0.00	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	7.75	5.16	5.68	0.00	2.07	1.03	0.52	1.55	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	7.26	4.23	6.05	0.60	1.21	0.60	0.00	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	11.41	7.61	6.65	1.58	0.95	0.63	0.32	0.95	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	9.06	5.33	5.33	0.53	0.53	0.00	0.53	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	4.60	4.60	6.32	1.15	0.57	0.57	0.00	2.30	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	8.23	7.20	8.23	3.09	1.54	0.51	0.51	0.51	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	10.61	8.49	3.54	2.83	0.71	2.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	5.11	7.94	5.11	2.27	1.13	1.13	0.00	1.70	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	4.99	9.57	7.07	1.66	1.66	0.83	0.42	0.83	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	8.61	3.13	4.70	2.35	0.00	0.00	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	7.93	4.59	5.01	1.25	0.42	0.42	0.00	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	6.04	4.18	4.65	0.93	1.86	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	8.70	2.68	3.35	0.67	0.67	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	11.76	3.74	1.07	1.07	1.60	0.53	0.53	1.07	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	12.12	7.27	3.23	0.81	1.21	0.40	0.00	2.83	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	6.42	5.51	0.92	2.75	0.00	0.00	0.00	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	6.22	5.33	5.33	0.00	0.89	0.89	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	11.40	2.85	2.28	0.57	1.14	0.00	0.00	1.14	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	9.20	3.83	1.53	0.00	0.77	0.00	0.00	1.53	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	11.49	5.47	2.19	0.00	0.00	0.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12.47	4.01	0.89	0.00	0.45	0.00	0.45	0.89	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	11.18	2.60	1.30	1.04	0.52	0.52	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	9.28	3.98	0.66	0.00	1.33	0.00	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	14.55	12.47	2.08	0.00	4.16	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	4.56	2.96	2.05	1.37	0.91	0.00	0.23	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	4.40	2.20	1.84	0.73	0.18	0.00	0.18	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	5.90	1.70	3.67	0.92	0.52	0.00	0.13	0.13	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	5.84	2.12	1.59	0.53	0.53	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	5.23	5.39	2.69	1.74	0.63	0.00	0.00	0.32	0.00
Mallassez-derived cells, donor3	11930-125I4	10.42	5.14	2.92	0.56	0.69	0.14	0.14	0.28	0.00
Mammary Epithelial Cell, donor1	11273-116H4	8.27	6.28	2.79	1.89	1.00	0.00	0.10	0.30	0.50
Mammary Epithelial Cell, donor2	11350-117G9	12.45	5.21	2.03	0.87	0.58	0.00	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	11.22	2.99	2.49	2.00	0.50	0.25	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	0.00	0.68	0.00	0.00	0.00	26.44	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	17.19	7.03	6.27	2.92	1.19	1.30	0.43	0.32	0.22
Mast cell, donor2	11565-120D8	30.91	13.08	9.21	2.38	4.46	7.73	0.89	1.19	0.30
Mast cell, donor3	11566-120D9	36.70	14.41	14.18	5.63	3.60	11.93	1.13	1.80	0.90
Mast cell, donor4	11567-120E1	30.32	9.93	8.16	4.08	1.77	3.19	0.71	1.06	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	12.20	12.09	6.43	1.33	1.55	1.11	0.67	0.33	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	29.77	10.51	7.00	1.75	1.75	8.17	0.58	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	14.34	10.10	5.97	2.29	2.41	0.00	0.46	0.34	0.34
Mast cell, expanded, donor8	11941-126A6	23.93	18.58	7.36	3.01	1.34	0.84	0.33	1.00	0.67
Melanocyte - dark, donor1	11502-119F8	8.95	7.16	2.09	1.09	1.39	0.00	0.10	0.10	0.10
Melanocyte - dark, donor2	11582-120F7	11.77	6.23	4.85	3.46	2.08	0.00	0.00	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	15.43	2.68	2.61	1.01	1.67	0.07	0.29	0.22	0.29
Melanocyte - light, donor1	11274-116H5	11.28	2.59	3.76	0.94	2.35	0.24	0.24	0.24	0.00
Melanocyte - light, donor2	11351-117H1	10.24	2.73	1.36	2.73	0.00	0.68	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	14.74	1.73	2.60	0.00	1.73	0.87	1.73	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	11.45	3.85	2.92	1.04	2.29	0.21	0.31	0.10	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	9.41	4.84	2.42	0.54	0.54	0.00	0.54	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	9.37	7.50	3.75	1.34	1.34	0.27	0.27	0.00	0.00
Meningeal Cells, donor1	11493-119E8	14.64	0.99	3.10	0.62	1.49	0.00	0.00	0.00	0.00
Meningeal Cells, donor2	11573-120E7	11.00	1.76	2.20	2.20	0.88	0.00	0.00	0.44	0.44
Meningeal Cells, donor3	11654-122E7	13.61	2.12	1.87	1.30	1.22	0.08	0.41	0.08	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	15.97	5.99	3.42	1.14	1.14	0.29	0.57	0.29	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	7.95	2.72	1.41	1.61	0.30	0.00	0.30	0.30	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	9.20	2.63	5.26	0.00	2.63	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	6.54	2.62	2.62	0.00	1.31	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	13.63	2.87	0.00	0.72	0.00	0.72	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	10.38	1.91	2.12	1.27	0.85	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	10.56	0.50	2.51	1.51	1.01	0.00	0.00	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	19.78	1.98	3.52	1.32	0.66	0.22	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	13.15	2.19	2.92	1.46	1.46	0.00	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	13.30	2.46	1.84	1.43	1.23	0.41	0.61	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	9.56	3.19	4.99	0.97	2.35	0.14	0.42	0.28	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	8.18	4.83	3.35	4.46	1.49	0.00	0.00	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	15.13	4.61	2.37	3.42	1.05	0.00	0.26	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	6.53	5.04	3.26	3.86	0.30	0.30	1.48	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	0.00	4.67	9.34	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	10.89	3.20	2.56	0.64	1.92	0.00	0.00	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	11.34	1.42	1.77	0.71	1.42	0.00	0.00	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	15.32	6.25	3.44	6.88	0.63	0.00	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	21.05	2.90	2.18	0.00	0.73	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	10.87	3.98	3.71	4.24	1.06	0.00	0.53	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	6.01	3.50	1.50	1.00	0.00	0.00	0.50	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	8.89	3.83	2.31	2.82	0.72	0.22	0.36	0.14	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	1.35	0.00	0.00	1.35	1.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	8.13	2.22	2.96	0.49	1.48	0.00	0.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	6.77	2.65	2.06	0.59	0.00	0.59	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	5.27	2.48	1.55	0.93	0.31	0.00	0.00	0.00	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	5.19	3.11	2.07	0.62	0.62	0.00	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	6.95	2.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	6.01	2.00	3.75	0.75	0.50	0.25	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	6.05	1.40	3.72	0.93	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	6.91	3.86	2.44	1.42	1.02	0.20	0.20	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	4.36	3.56	2.38	0.79	0.00	0.00	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	5.31	0.00	3.54	1.77	0.88	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	6.46	2.66	1.14	1.90	0.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	6.58	2.97	3.40	0.21	1.27	0.00	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	1.84	2.76	0.92	1.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	2.98	1.49	2.68	0.30	0.89	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	1.68	5.03	0.00	0.00	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	5.52	3.51	1.51	0.50	0.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	4.04	2.61	1.43	0.95	1.19	0.24	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.08	0.55	2.21	0.55	0.00	0.00	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	5.07	2.30	1.38	0.46	0.23	0.23	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	4.63	1.26	1.89	0.21	0.21	0.21	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	5.10	2.24	1.02	0.82	0.41	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	5.58	2.79	1.29	0.00	0.64	0.21	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	5.11	2.45	1.33	1.11	0.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	4.60	1.97	1.31	0.66	0.00	0.66	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	1.01	2.03	2.03	0.51	0.51	0.00	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	0.00	0.00	0.00	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	4.35	3.26	1.63	0.27	0.54	0.00	0.27	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	4.41	1.76	0.59	0.59	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	1.09	0.00	0.00	1.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	6.25	2.88	1.44	1.44	0.00	0.48	0.48	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	4.00	3.60	0.40	0.40	0.80	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	6.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.51	3.50	2.00	0.50	1.50	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	26.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	2.04	4.08	0.00	0.00	0.00	0.00	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	10.51	3.07	0.44	0.44	0.44	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	0.00	2.21	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	4.48	1.92	1.28	3.20	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	7.93	6.20	1.98	0.50	0.00	1.24	0.00	0.50	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.18	0.70	0.70	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	2.21	2.21	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	9.57	3.42	2.39	0.68	0.68	0.34	0.00	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	5.25	0.88	0.88	1.75	0.00	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	6.04	1.78	2.84	1.78	0.00	0.00	0.36	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	14.59	3.93	3.65	0.84	0.00	0.00	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	9.14	2.49	1.25	0.00	0.00	0.42	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	9.32	1.75	1.75	3.50	0.58	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	12.37	3.62	3.02	0.00	0.30	0.30	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	12.10	3.34	2.09	1.25	0.00	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	7.22	7.22	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	7.39	5.54	2.77	1.85	0.00	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	13.66	3.41	0.57	0.57	0.57	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	5.25	2.49	1.24	1.80	0.69	0.14	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	9.33	4.66	1.30	1.04	0.78	0.26	0.78	0.52	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	8.15	2.57	3.00	0.86	0.00	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	5.08	2.54	2.54	1.91	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	8.01	4.80	2.40	0.53	0.00	0.00	0.00	0.53	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	7.48	6.59	3.59	0.30	0.90	0.00	0.60	0.30	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	5.23	2.83	2.54	2.12	0.99	0.00	0.42	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	12.10	7.01	1.59	0.64	0.64	0.32	0.00	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	8.62	4.86	3.98	1.33	0.44	0.22	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	12.51	1.52	3.03	0.76	0.00	0.00	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	7.39	5.68	2.84	1.70	0.57	0.00	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	7.62	6.64	5.41	0.74	0.00	0.25	0.25	0.00	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	7.17	1.30	5.87	1.30	1.30	0.00	1.30	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	5.88	4.70	3.53	1.18	0.29	0.00	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	7.21	5.77	5.77	1.73	0.29	0.29	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	4.53	3.71	4.95	0.41	0.82	0.00	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	5.66	4.47	2.68	0.60	0.60	0.00	0.30	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	3.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	1.78	3.56	1.78	1.78	0.00	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	7.56	3.61	1.97	0.66	1.97	0.00	0.00	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	6.31	4.21	2.10	1.05	2.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	4.55	2.37	1.38	0.20	0.00	0.00	0.20	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	12.11	1.86	2.79	0.93	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	4.51	2.63	3.38	1.13	0.75	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	4.79	4.53	2.93	0.80	0.00	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	3.51	4.07	1.47	0.90	0.23	0.00	0.45	0.00	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	7.37	2.21	1.47	0.74	0.00	0.00	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	6.96	3.30	3.30	0.37	1.10	0.37	0.00	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	3.11	1.56	3.11	4.67	4.67	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	2.14	1.07	1.60	1.07	0.00	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	3.86	0.00	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	12.12	5.05	2.02	0.00	1.01	0.00	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	2.95	0.42	2.11	0.84	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	0.00	4.09	5.45	0.00	0.00	0.00	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	1.91	1.91	0.64	0.00	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1.62	0.81	0.00	0.81	1.62	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	3.02	0.00	0.00	0.00	0.00	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	17.13	0.00	11.42	0.00	11.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	13.05	0.00	9.79	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	4.75	4.75	0.00	0.00	0.00	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	12.55	12.55	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	9.69	3.02	2.80	1.94	0.43	0.43	0.43	0.00	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	6.27	3.14	4.70	1.57	1.05	0.52	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	16.69	0.00	0.00	0.67	0.67	0.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	15.86	0.83	2.09	0.42	0.42	0.00	0.00	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	4.18	2.66	2.09	1.14	0.95	0.00	0.19	0.00	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	1.60	3.19	1.60	3.19	0.00	0.00	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	12.92	2.04	1.36	0.00	0.00	0.00	0.00	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	9.19	1.84	5.51	1.84	0.00	0.00	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	15.49	3.35	1.67	2.09	0.00	0.42	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	13.95	1.86	0.46	0.93	0.93	0.00	0.23	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	15.67	2.16	1.08	0.27	0.54	0.00	0.00	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	7.78	3.36	1.68	1.05	1.05	0.00	0.42	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00	22.27	0.00	0.00	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	15.88	3.47	2.98	0.50	1.99	0.00	0.00	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	7.04	3.79	1.89	1.08	1.62	0.00	0.54	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	14.05	2.49	1.36	0.68	0.23	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	10.94	1.63	1.14	0.33	0.82	0.00	0.33	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	6.74	3.46	3.65	0.91	0.73	0.18	0.18	0.18	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	12.20	2.65	2.65	1.06	0.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	17.41	2.40	1.20	0.60	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	4.27	7.22	6.89	4.27	0.66	0.33	0.00	0.33	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	11.06	2.44	1.46	0.33	0.81	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	9.00	2.82	2.82	0.71	0.53	0.00	0.00	0.18	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	11.25	4.92	2.11	0.70	0.00	0.00	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	9.19	2.76	0.46	0.92	1.38	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	21.85	4.82	1.93	0.64	0.64	0.32	0.32	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	6.21	6.21	6.90	4.83	3.45	0.34	0.69	0.00	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	7.59	2.53	7.59	15.17	10.11	0.00	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	7.80	1.56	1.56	0.89	0.45	0.22	0.00	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	10.58	1.69	0.85	1.69	1.69	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	5.22	2.14	1.66	3.32	1.42	0.00	0.47	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	20.60	3.86	1.29	2.15	0.86	0.00	0.00	0.00	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	18.06	9.03	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	11.00	1.33	1.33	0.67	0.67	0.00	0.33	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	2.25	1.35	2.25	0.00	0.45	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	9.13	1.59	1.19	1.19	0.40	0.00	0.79	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	13.00	2.79	1.86	2.79	0.00	0.00	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	7.57	4.54	4.54	1.51	1.51	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	7.50	1.30	0.98	0.98	0.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	18.30	2.61	0.87	0.00	2.18	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	8.14	0.90	0.90	1.81	0.45	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	9.70	3.53	1.76	0.88	0.88	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	11.30	2.66	2.66	0.66	1.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	12.40	3.47	1.49	0.99	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	13.78	1.15	1.53	1.91	0.38	0.00	0.77	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	9.98	2.72	2.72	3.02	2.12	0.30	0.91	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	7.07	2.21	2.87	1.77	0.88	0.00	0.44	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	11.52	5.42	0.68	4.07	2.71	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	0.00	0.00	20.44	10.22	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	14.02	4.27	3.05	1.22	2.44	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	10.70	2.52	0.31	0.63	0.63	0.00	0.00	0.63	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	10.90	2.12	1.51	1.51	0.00	0.00	0.30	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	14.24	1.58	1.58	1.58	2.37	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	4.53	4.53	9.07	3.40	0.00	0.00	2.27	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	5.06	15.17	20.23	0.00	5.06	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	6.96	3.11	1.61	1.24	0.62	0.25	0.25	0.12	0.37
Myoblast, donor2	11322-117D8	7.67	4.79	3.07	2.88	1.53	0.00	0.19	0.19	0.00
Myoblast, donor3	11398-118D3	6.56	1.35	2.02	1.35	1.68	0.17	0.17	0.17	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	15.32	4.96	1.46	0.88	1.17	0.15	0.29	0.29	0.00
Natural Killer Cells, donor1	11230-116C6	23.37	19.68	10.46	3.69	0.31	15.99	0.00	4.31	0.62
Natural Killer Cells, donor2	11311-117C6	28.95	30.16	9.35	3.32	1.21	10.55	0.30	2.11	0.60
Natural Killer Cells, donor3	11387-118C1	34.23	19.69	12.15	4.05	1.47	12.70	0.18	3.87	0.92
Neural stem cells, donor1	11275-116H6	22.50	2.18	2.90	2.90	1.09	0.00	0.00	0.00	0.00
Neural stem cells, donor2	11352-117H2	9.63	0.00	0.00	1.93	0.00	0.00	0.00	1.93	3.85
Neurons, donor1	11494-119E9	21.62	7.97	5.69	3.41	1.14	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	20.70	2.86	4.84	3.08	1.32	0.22	1.10	0.22	0.44
Neurons, donor3	11655-122E8	13.98	3.29	4.93	1.64	4.11	0.82	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	3.71	108.58	26.91	17.63	0.00	24.13	0.00	15.78	0.93
Neutrophils, donor2	11314-117C9	11.60	63.78	14.49	14.49	2.90	11.60	0.00	17.39	0.00
Neutrophils, donor3	11390-118C4	8.55	124.61	27.49	15.27	1.83	11.00	2.44	11.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	15.20	6.89	4.16	2.97	2.02	0.00	0.59	0.00	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	14.00	5.86	6.51	1.30	2.93	0.00	0.33	0.00	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	11.63	3.61	5.01	1.00	1.20	0.00	0.20	0.20	0.20
Olfactory epithelial cells, donor1	11933-125I7	10.60	6.06	3.44	0.69	1.10	0.41	0.00	0.28	0.55
Olfactory epithelial cells, donor2	11934-125I8	15.05	5.36	4.49	1.01	1.88	0.29	0.14	0.29	0.29
Olfactory epithelial cells, donor3	11935-125I9	9.87	6.58	3.63	1.93	1.25	0.11	0.00	0.23	0.11
Olfactory epithelial cells, donor4	11936-126A1	17.43	4.38	2.82	1.75	1.85	0.00	0.49	0.00	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	22.27	7.22	2.41	2.41	1.20	0.00	0.00	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	10.42	1.91	3.62	1.91	1.28	0.43	0.21	0.00	0.21
Osteoblast - differentiated, donor2	11353-117H3	6.86	5.72	3.43	3.43	2.29	0.00	0.00	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	9.31	6.21	0.62	0.62	1.24	0.00	0.62	0.00	0.62
Osteoblast, donor1	11277-116H8	15.63	2.74	5.47	3.91	0.59	0.20	1.56	0.00	0.00
Osteoblast, donor2	11354-117H4	14.05	3.51	2.11	0.70	0.70	0.00	0.00	0.00	0.70
Osteoblast, donor3	11426-118G4	15.82	3.02	3.73	2.13	1.07	0.53	0.18	0.18	0.53
Pancreatic stromal cells, donor1	11249-116E7	11.62	2.78	3.45	2.11	1.68	0.25	0.51	0.08	0.25
Pericytes, donor1	11491-119E6	10.90	4.34	5.34	1.34	1.78	0.22	0.89	0.11	0.33
Pericytes, donor2	11571-120E5	10.41	2.49	6.34	1.36	1.81	0.23	0.23	0.00	0.23
Pericytes, donor3	11652-122E5	14.24	3.26	2.85	1.63	1.22	0.00	0.20	0.41	0.00
Perineurial Cells, donor1	11499-119F5	19.78	3.39	3.39	0.90	1.92	0.11	0.23	0.11	0.34
Perineurial Cells, donor2	11579-120F4	14.54	5.80	3.96	2.48	1.38	0.00	0.37	0.09	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	16.89	17.53	8.29	2.55	2.23	4.46	0.64	2.23	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	13.22	25.47	9.79	5.63	1.96	3.92	0.00	2.20	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	17.99	19.15	10.09	4.40	1.29	3.36	0.39	2.72	0.13
Placental Epithelial Cells, donor1	11278-116H9	7.89	5.26	2.39	4.07	0.00	0.00	0.72	0.72	0.00
Placental Epithelial Cells, donor2	11355-117H5	6.65	4.44	3.33	3.33	1.11	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	11.39	5.30	4.52	3.34	1.18	0.00	0.79	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.54	1.90	3.48	0.32	1.27	0.32	0.32	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	6.19	3.75	2.06	2.06	1.13	0.00	0.19	0.19	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	10.44	6.13	4.83	3.26	2.09	0.00	0.26	0.00	0.13
Preadipocyte - breast, donor2	11328-117E5	9.68	2.93	2.70	1.35	0.68	0.00	0.23	0.45	0.23
Preadipocyte - omental, donor1	11468-119C1	9.16	4.69	2.77	1.70	0.64	0.32	0.21	0.21	0.11
Preadipocyte - omental, donor2	11329-117E6	5.24	5.24	1.31	2.62	0.00	0.00	0.44	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	12.32	3.87	3.44	2.01	1.29	0.29	0.43	0.14	0.14
Preadipocyte - perirenal, donor1	11469-119C2	5.91	0.98	3.94	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	17.20	3.07	2.76	3.99	1.23	0.00	0.61	0.61	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	14.87	3.01	2.66	0.89	1.06	0.00	0.18	0.18	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	16.35	4.26	2.38	2.04	2.04	0.34	0.17	1.02	0.17
Preadipocyte - visceral, donor1	11280-116I2	15.74	3.45	3.54	1.58	1.02	0.28	0.28	0.19	0.28
Preadipocyte - visceral, donor2	11357-117H7	15.19	2.30	1.84	2.30	0.46	0.00	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	11.70	2.82	2.19	0.84	0.52	0.21	0.00	0.42	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	8.45	5.28	1.51	1.51	0.45	0.30	0.00	0.91	0.00
Prostate Epithelial Cells, donor2	11331-117E8	5.01	7.45	3.39	1.49	0.81	0.41	0.00	0.68	0.14
Prostate Epithelial Cells, donor3	11404-118D9	3.18	4.47	2.69	1.47	0.67	0.00	0.12	0.12	0.12
Prostate Stromal Cells, donor1	11254-116F3	10.14	3.30	2.73	2.28	0.23	0.46	0.11	0.11	0.34
Prostate Stromal Cells, donor2	11332-117E9	13.45	2.51	3.23	1.97	0.72	0.36	0.00	0.00	0.00
Prostate Stromal Cells, donor3	11405-118E1	9.18	5.32	4.07	3.23	1.98	0.31	0.10	0.52	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	17.88	2.92	1.82	0.73	1.09	0.00	0.00	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	12.61	5.48	2.01	0.90	0.69	0.21	0.42	0.21	0.07
Renal Epithelial Cells, donor1	11517-119H5	12.68	3.55	0.51	0.00	1.52	0.51	1.52	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	10.67	2.13	4.27	0.71	0.00	0.71	0.00	0.71	0.71
Renal Epithelial Cells, donor3	11678-122H4	15.03	9.42	1.80	1.48	1.27	0.11	0.11	0.32	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	10.89	2.72	1.36	0.68	1.36	0.00	0.00	0.68	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	9.57	2.70	2.83	0.67	1.62	0.27	0.27	0.27	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	9.32	4.00	2.44	1.11	1.78	0.00	0.00	0.67	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	15.31	3.99	2.00	1.33	0.67	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	20.69	2.86	3.08	0.88	0.44	0.22	0.22	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	13.79	2.51	3.76	0.63	0.63	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	12.21	5.83	3.05	1.11	1.11	0.00	0.00	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	16.64	1.61	2.95	0.27	0.00	0.00	0.27	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	9.70	3.80	3.37	0.42	1.69	0.00	0.00	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	15.04	3.47	3.86	0.19	1.16	0.00	0.19	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	15.04	4.15	3.89	1.30	1.04	0.00	1.04	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	10.52	5.97	1.71	0.85	0.57	0.28	0.57	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	9.26	2.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	8.28	6.02	5.02	1.25	2.26	0.00	0.25	0.50	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	6.68	9.49	6.95	5.61	1.74	0.13	1.20	0.53	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	15.19	0.89	1.79	2.68	0.00	0.89	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	9.36	7.71	9.36	4.95	2.20	1.65	1.65	0.00	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	12.76	2.32	1.16	1.74	1.16	0.58	1.74	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	15.60	3.25	4.03	0.65	0.52	0.00	0.13	0.00	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	15.29	3.08	3.38	1.09	1.19	0.30	0.30	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	21.19	2.45	3.90	1.67	1.23	0.33	0.89	0.33	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	25.93	3.35	7.57	0.99	2.23	0.25	0.12	0.12	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	20.51	5.36	3.50	2.33	1.28	0.58	0.47	0.12	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	17.10	4.16	4.85	2.08	1.85	0.00	0.46	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	15.47	2.33	5.07	0.96	0.96	0.27	0.41	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	20.12	3.78	3.18	1.82	2.12	0.00	0.45	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	21.50	3.76	2.51	1.97	1.25	0.18	0.54	0.00	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	22.38	3.16	5.45	0.86	2.73	0.00	0.29	0.29	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	18.67	5.15	5.79	1.07	1.61	0.11	0.64	0.11	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	17.26	2.88	6.42	1.11	1.77	0.22	0.22	0.44	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	17.59	2.87	5.93	0.57	0.76	0.38	0.38	0.00	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	15.93	3.35	2.70	0.93	1.02	0.28	0.19	0.09	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	21.23	5.45	3.19	1.13	0.75	0.38	0.38	0.38	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	11.81	1.99	6.24	1.46	1.19	0.13	0.53	0.00	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	21.61	3.50	2.24	1.36	1.65	0.29	0.78	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	16.80	4.01	4.58	2.10	1.53	0.76	0.57	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	17.19	3.31	5.66	0.64	1.17	0.64	0.11	0.32	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	15.70	3.36	3.36	0.84	0.84	0.56	0.56	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	15.72	4.44	6.67	0.51	0.85	0.17	0.34	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	17.50	2.01	5.65	0.55	2.19	0.00	0.18	0.00	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	15.94	4.05	4.05	1.23	1.84	0.12	0.37	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	16.12	4.16	5.64	1.88	1.07	0.54	0.27	0.13	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	17.22	3.07	6.37	0.94	1.65	0.47	0.47	0.00	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	16.07	5.56	4.17	1.19	1.19	0.40	0.60	0.20	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	18.47	4.91	4.91	1.87	1.17	0.23	0.47	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	21.15	3.53	4.77	0.41	1.87	0.21	0.41	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	16.37	3.32	5.09	1.33	0.66	0.44	0.22	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	14.41	3.76	3.13	2.51	1.04	0.21	0.21	0.00	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	18.44	4.04	5.79	1.48	2.29	0.27	0.13	0.27	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	14.48	2.38	3.75	1.02	1.53	0.51	0.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	14.27	5.01	6.17	0.96	1.16	0.58	0.19	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	14.44	2.41	5.33	0.86	2.06	0.34	0.34	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	15.91	2.47	3.29	0.82	1.23	0.14	0.14	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	14.61	3.94	2.46	1.15	1.15	0.49	0.16	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	19.77	2.39	4.60	0.34	1.53	0.00	0.17	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	18.94	6.66	5.77	1.78	1.33	0.30	0.59	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	18.13	3.20	5.06	1.60	1.33	0.53	0.80	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	21.15	6.50	8.71	0.69	3.32	0.14	0.00	0.28	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	21.19	4.52	8.81	1.19	1.67	0.24	0.48	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	23.78	4.03	5.44	1.61	2.02	0.20	0.81	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	18.74	5.93	8.19	1.04	2.64	0.19	0.66	0.19	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	16.77	9.78	12.23	3.49	1.40	0.35	1.75	0.35	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	13.60	4.84	4.23	2.42	3.32	0.60	0.91	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	19.09	5.26	6.61	1.35	2.20	0.61	0.24	0.49	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	26.20	15.43	8.73	5.24	2.47	1.16	1.02	0.87	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	20.08	12.17	7.30	3.04	3.04	0.61	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	17.78	5.43	8.14	1.51	2.71	1.51	0.30	0.90	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	18.55	9.27	3.17	3.85	3.17	0.23	0.23	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	27.56	10.48	7.49	3.29	2.40	0.60	0.60	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	14.29	8.27	10.39	3.07	2.83	0.71	0.35	0.35	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	14.51	6.19	4.70	3.63	1.28	0.43	0.85	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	25.84	6.61	5.41	2.40	1.80	0.00	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	16.36	2.26	4.14	1.32	1.32	0.00	0.00	0.00	0.38
Schwann Cells, donor2	11578-120F3	13.61	0.00	0.00	0.00	6.80	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	15.12	2.19	3.72	0.44	1.75	0.00	0.22	0.00	0.44
Sebocyte, donor1	11220-116B5	14.24	2.74	2.19	1.10	1.10	0.55	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	6.89	5.51	1.38	0.00	0.00	0.00	0.00	0.00	0.46
Sebocyte, donor3	11378-118B1	10.10	5.36	1.44	2.06	2.06	0.21	0.00	0.62	0.21
Sertoli Cells, donor1	11255-116F4	13.25	1.66	9.94	3.31	0.00	0.00	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	11.30	5.65	2.82	0.00	2.82	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	15.84	3.87	5.10	1.50	1.94	0.00	0.18	0.44	0.26
Skeletal Muscle Cells, donor2	11358-117H8	10.84	3.61	0.72	2.17	1.45	0.00	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	16.72	5.85	1.67	0.84	0.84	0.00	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	11.47	2.36	1.89	1.10	1.10	0.00	0.31	0.00	0.31
Skeletal Muscle Cells, donor5	11455-119A6	10.85	2.38	2.38	0.00	1.04	0.15	0.45	0.00	0.15
Skeletal Muscle Cells, donor6	11459-119B1	11.54	0.92	2.00	0.92	1.54	0.15	0.31	0.00	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	14.24	4.66	3.28	2.39	0.76	0.00	0.88	0.00	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	12.70	4.14	3.14	2.57	1.57	0.00	0.57	0.00	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	16.27	3.47	2.28	1.09	0.79	0.10	0.30	0.10	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	11.88	4.04	3.62	1.85	1.94	0.08	0.42	0.08	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	18.09	1.45	2.90	2.17	1.45	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	12.66	3.58	4.40	1.24	1.51	0.00	0.41	0.14	0.28
Skin - palm, donor1	10286-104F7	2.69	8.06	2.69	2.69	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	5.48	6.34	1.73	1.59	0.43	0.00	0.14	0.43	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	2.45	17.99	8.18	7.36	1.64	0.82	1.64	2.45	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	6.62	4.93	1.95	1.04	0.52	0.00	0.26	0.52	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	5.56	4.45	3.06	1.39	0.70	0.00	0.28	0.70	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	5.20	5.20	2.53	1.97	0.56	0.00	0.00	0.00	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	24.95	12.05	7.82	5.29	1.69	0.00	1.48	0.63	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	4.50	5.10	3.07	2.25	0.75	0.07	0.22	0.15	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	14.50	4.32	3.70	0.62	1.23	0.00	0.31	0.62	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	12.45	6.23	6.23	1.33	1.33	0.44	0.22	0.67	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	15.28	4.11	4.11	4.11	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	17.46	4.64	2.21	1.77	0.22	0.22	0.22	0.44	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	16.93	2.36	1.97	3.15	1.18	0.39	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	15.45	0.77	1.55	3.09	0.00	2.32	0.77	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	12.01	3.00	4.00	1.00	2.00	0.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	19.16	3.73	3.33	3.19	0.93	0.13	0.40	0.27	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	13.74	5.76	2.44	1.99	1.77	0.00	0.44	0.44	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	8.19	2.18	4.61	1.41	0.38	0.38	0.13	0.26	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	8.79	0.65	2.60	1.30	1.30	0.00	0.33	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	11.81	2.07	3.25	1.18	1.18	0.00	0.00	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	10.39	3.27	1.57	0.71	0.57	0.14	0.00	0.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	13.50	1.46	2.60	0.65	1.14	0.00	0.16	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	7.61	6.09	5.48	2.74	3.04	0.00	0.30	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	16.92	5.30	4.55	4.29	1.26	0.25	1.77	0.51	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	0.00	6.12	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	13.83	5.25	1.43	2.38	0.48	1.43	0.48	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	6.93	1.77	1.62	1.03	0.59	0.00	0.15	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	7.10	2.37	2.58	1.94	0.86	0.00	0.00	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	13.12	3.04	2.62	0.52	0.21	0.10	0.21	0.00	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	19.80	2.32	1.86	2.01	0.31	0.62	0.31	0.31	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	17.25	4.31	4.31	2.16	2.16	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	8.37	2.39	1.49	0.30	0.30	0.60	0.60	0.00	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	14.00	3.41	6.49	0.68	1.02	0.00	0.00	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	17.83	5.42	3.14	2.59	0.55	0.08	0.16	0.00	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	12.88	5.54	2.01	1.91	1.81	1.01	0.70	1.11	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	20.93	5.69	2.96	2.28	1.59	0.23	0.00	0.23	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	16.30	3.62	4.23	1.21	0.60	0.00	0.00	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	16.96	2.91	2.38	0.53	0.26	0.00	0.00	0.53	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	10.12	1.73	3.06	0.40	0.40	0.13	0.27	0.27	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	10.64	4.01	3.51	1.88	0.38	0.13	0.00	0.25	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	4.57	2.28	2.79	3.80	0.25	0.25	0.76	0.00	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	19.00	1.81	3.32	1.96	1.21	0.15	0.45	1.06	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	21.00	3.00	3.00	2.25	1.50	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	11.63	28.43	0.00	1.29	2.58	1.29	1.29	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	24.18	4.65	2.79	5.12	0.93	0.47	1.40	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	13.13	5.55	1.51	2.02	1.01	0.50	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	12.85	7.21	4.07	0.00	1.25	0.00	0.31	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	12.09	3.24	1.47	1.18	1.18	0.00	0.00	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	15.91	1.33	2.17	0.83	0.75	0.17	0.17	0.00	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	12.15	4.20	2.34	2.80	0.47	0.00	0.00	0.00	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	18.42	2.73	4.03	1.44	0.29	0.43	0.14	0.29	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	23.20	3.57	1.78	2.04	0.51	1.53	0.00	0.00	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	14.10	1.69	2.07	0.38	0.38	1.13	0.38	0.38	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	12.16	4.89	3.63	1.26	1.68	0.00	0.00	0.14	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	17.85	3.52	2.18	1.76	0.84	0.08	0.34	0.00	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	14.76	3.33	1.90	0.48	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	15.66	4.40	1.47	1.96	0.49	0.49	0.24	0.49	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	12.59	3.54	2.21	1.55	0.88	0.44	0.44	0.88	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	12.29	0.59	2.34	1.46	0.88	0.29	0.29	0.29	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	7.19	3.50	4.08	3.89	1.17	0.00	0.00	0.19	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	8.20	2.64	2.38	1.32	1.06	0.79	0.26	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	7.07	4.84	5.21	5.58	4.09	0.37	0.37	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	8.26	5.03	3.59	1.80	0.00	0.72	0.72	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	10.50	0.28	1.42	0.57	0.28	0.00	0.00	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	4.73	1.97	4.33	1.58	1.18	0.39	0.39	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	6.86	1.78	2.29	2.54	1.27	0.00	0.25	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	9.58	3.59	3.19	1.20	0.80	0.00	0.40	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	9.20	3.76	1.25	2.51	0.84	0.00	0.42	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	3.67	1.83	2.75	2.29	1.83	0.46	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	10.27	5.72	4.21	2.86	0.84	0.34	0.84	0.67	0.17
Synoviocyte, donor2	11368-117I9	8.72	6.20	2.68	3.02	1.68	0.00	0.50	0.84	0.34
Synoviocyte, donor3	11440-118H9	8.27	6.70	3.57	1.56	2.46	0.22	0.22	0.00	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	17.51	2.50	2.86	1.43	1.07	0.00	0.00	0.36	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	5.95	9.91	0.00	3.96	0.00	0.00	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	15.05	2.55	3.70	1.85	2.08	0.69	0.69	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	9.32	1.58	1.43	0.72	0.43	0.07	0.07	0.07	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	9.28	2.71	3.87	0.39	1.16	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	6.87	2.29	4.58	0.57	0.00	0.00	0.00	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	6.89	8.86	6.64	6.64	2.09	0.37	0.86	0.12	0.12
Urethra, donor2	10319-105A4	5.40	5.40	3.60	7.19	1.80	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	9.56	5.58	3.45	1.06	1.33	0.00	0.27	0.53	0.00
Urothelial Cells, donor2	11600-120H7	10.41	5.21	3.20	0.40	0.00	0.00	0.00	0.40	0.40
Urothelial Cells, donor3	11681-122H7	5.96	5.50	2.52	0.69	1.38	0.00	0.23	0.23	0.23
Urothelial cells, donor0	11216-116B1	8.69	9.14	2.01	1.56	0.89	0.00	0.00	0.45	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	18.69	59.62	8.90	0.89	3.56	4.45	0.89	5.34	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	18.58	68.62	25.73	4.29	5.72	2.86	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	24.64	40.39	8.21	4.79	4.11	0.68	0.68	3.42	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	20.66	45.11	5.51	3.10	1.72	0.69	1.03	2.07	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	15.11	52.29	8.72	1.74	0.58	0.58	0.58	3.49	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	9.37	48.94	17.70	2.08	1.04	1.04	0.00	3.12	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	19.27	44.05	16.52	3.67	3.67	1.84	1.84	3.67	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	16.43	46.56	9.13	6.39	2.74	0.91	0.00	4.56	0.00
Wilms' tumor cell line:G-401	10809-111A8	16.53	3.45	3.58	0.74	0.74	0.12	0.12	0.00	0.25
Wilms' tumor cell line:HFWT	10597-108E3	8.80	0.88	2.64	1.76	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	7.82	3.35	2.79	1.40	0.28	0.00	0.28	0.28	0.00
achilles tendon, donor2	10292-104G4	6.20	0.00	6.20	2.07	0.00	2.07	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	17.34	1.02	1.78	0.51	1.27	1.02	0.25	0.76	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	23.68	3.02	2.32	0.00	0.93	0.46	0.46	0.23	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	41.07	6.89	6.89	0.71	3.09	0.12	0.36	0.24	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	19.86	4.08	1.63	0.00	0.82	0.27	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	13.77	2.53	2.25	0.28	1.12	0.00	0.00	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	11.42	8.25	3.17	1.48	1.48	0.00	0.00	0.63	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	14.16	6.26	2.72	2.45	0.82	0.00	0.00	1.09	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	10.58	4.41	2.20	0.44	1.76	1.76	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	10.21	6.94	4.49	0.00	0.82	0.41	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	24.07	8.54	4.66	0.78	3.11	0.39	0.00	0.78	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	10.67	1.66	0.55	0.00	1.10	0.18	0.00	0.18	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	11.70	3.90	0.00	3.90	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	19.98	4.88	2.32	0.23	2.32	0.23	0.00	0.93	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	10.36	8.28	2.59	0.26	1.81	0.00	0.26	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	6.43	5.26	1.75	0.00	0.88	0.58	0.00	0.29	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	6.51	2.79	1.86	0.00	0.46	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	7.40	3.29	3.29	0.82	0.82	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	4.91	1.53	0.61	0.00	1.53	0.31	0.00	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	7.25	1.28	0.85	0.85	0.85	0.43	0.00	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	7.89	2.43	2.73	0.61	0.91	0.30	0.61	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	10.59	2.65	1.68	0.24	0.00	0.24	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	8.02	4.45	2.23	0.22	2.23	0.22	0.45	0.67	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	5.34	5.00	4.67	3.34	1.33	0.67	0.33	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	3.72	5.57	5.57	0.00	1.86	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	11.68	6.03	3.77	1.51	0.75	0.38	0.00	0.75	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	9.16	3.05	5.23	0.44	2.18	0.87	0.00	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	5.62	1.87	1.87	5.62	0.00	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	10.36	1.88	3.06	1.88	0.71	0.24	0.00	0.24	0.24
adipose tissue, adult, pool1	10010-101C1	6.98	5.12	4.34	3.72	3.41	0.31	0.78	0.16	0.00
adipose, donor1	10184-103D4	15.83	14.07	20.52	4.10	7.04	0.59	0.00	1.17	0.59
adipose, donor2	10185-103D5	23.52	4.06	2.84	0.41	0.81	0.00	0.00	0.81	0.41
adipose, donor3	10186-103D6	15.79	4.90	3.54	0.82	2.45	0.00	0.54	0.27	0.54
adipose, donor4	10187-103D7	21.67	5.20	1.73	0.87	1.73	1.73	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	13.57	2.05	3.00	1.58	1.58	0.16	0.16	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	14.55	14.55	10.91	10.91	7.28	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	9.87	10.94	5.60	1.87	1.73	0.93	0.13	0.93	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	13.93	10.72	3.93	2.50	1.43	1.07	0.71	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	4.64	7.65	3.94	3.01	1.16	0.23	1.16	0.70	0.23
amniotic membrane cells, donor2	12236-129G4	6.76	6.76	2.70	3.04	1.01	0.34	0.00	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	2.95	5.60	2.65	1.47	1.18	0.00	0.29	0.00	0.29
amygdala - adult, donor10196	10167-103B5	37.95	4.74	9.49	2.37	1.19	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	29.60	5.68	8.72	7.71	2.84	0.41	0.41	0.20	0.00
amygdala, newborn, donor10223	10360-105E9	18.08	4.52	2.90	3.87	0.32	5.49	1.29	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	19.61	8.40	3.95	5.60	1.66	0.00	0.25	0.51	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	22.50	3.75	3.53	0.44	1.10	0.22	0.00	0.22	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	35.41	1.34	3.67	3.67	1.67	0.00	0.33	0.00	0.00
aorta, adult, pool1	10052-101G7	19.22	4.90	6.08	3.33	1.57	0.39	0.59	0.20	0.20
appendix, adult	10189-103D9	14.75	12.81	4.27	3.88	0.39	0.00	1.55	1.16	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	8.94	8.94	3.78	2.41	1.72	0.00	1.03	0.34	0.00
artery, adult	10190-103E1	8.15	4.08	5.43	6.79	1.36	0.00	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	35.35	4.93	5.22	3.91	0.72	0.00	0.58	0.00	0.14
b cell line:RPMI1788	10427-106D4	20.22	5.65	3.72	0.74	0.74	1.93	0.15	1.04	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	12.76	3.88	2.50	0.55	1.11	0.55	0.28	0.28	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	10.62	3.87	3.27	1.59	0.60	0.10	0.10	0.30	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	2.01	2.18	2.51	2.68	0.17	0.00	0.17	0.33	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	2.24	3.91	2.80	2.80	1.68	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	14.56	5.21	3.37	3.04	1.41	0.22	0.43	0.33	0.22
blood, adult, pool1	10053-101G8	17.72	31.00	4.43	2.21	2.21	2.21	2.21	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	4.28	1.71	0.00	1.71	1.71	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	16.20	4.72	4.72	3.37	3.37	0.67	0.67	0.00	0.00
brain, adult, donor1	10084-102B3	41.00	2.05	11.28	6.15	1.03	0.00	2.05	0.00	0.00
brain, adult, pool1	10012-101C3	36.19	4.01	7.02	4.90	2.12	0.22	0.67	0.00	0.56
brain, fetal, pool1	10085-102B4	40.07	8.01	10.69	0.00	2.67	0.00	2.67	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	5.95	10.90	10.24	5.29	0.00	0.33	0.66	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	8.61	6.49	6.24	3.74	0.75	0.50	0.62	0.12	0.37
breast, adult, donor1	10080-102A8	10.73	8.84	1.89	1.89	1.26	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	8.38	0.89	2.03	0.38	0.38	0.00	0.13	0.13	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	8.66	3.09	3.09	1.24	2.16	0.31	0.93	0.31	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	4.83	2.07	0.46	0.46	0.00	0.00	0.00	0.23	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	4.60	1.45	3.87	0.73	1.21	0.00	0.24	0.24	0.24
carcinoid cell line:NCI-H1770	10703-109H1	20.22	1.88	2.82	0.47	0.94	0.00	0.47	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	6.13	0.77	1.75	1.75	0.11	0.11	0.00	0.00	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	19.33	3.49	4.44	1.27	0.63	0.00	0.32	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	14.37	4.79	6.12	2.40	1.60	0.53	0.27	1.06	0.53
caudate nucleus - adult, donor10196	10177-103C6	27.63	5.76	5.76	2.30	4.61	1.15	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	35.81	6.02	9.37	6.36	2.18	0.17	1.00	0.00	0.33
caudate nucleus, adult, donor10258	10379-105H1	38.21	3.82	5.35	3.06	1.53	0.00	2.29	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	27.10	3.66	4.76	4.39	1.10	4.76	0.73	0.37	0.37
cerebellum - adult, donor10196	10173-103C2	37.87	2.91	2.91	5.83	0.00	0.00	2.91	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	27.97	17.08	11.74	9.61	4.06	0.00	1.28	0.00	1.07
cerebellum, adult, pool1	10083-102B2	32.42	8.97	8.97	4.14	2.07	0.00	0.69	0.00	0.69
cerebellum, newborn, donor10223	10357-105E6	13.28	17.44	20.76	28.23	4.15	0.83	4.15	0.00	1.66
cerebral meninges, adult	10188-103D8	29.50	3.78	7.82	3.78	0.76	0.50	0.50	0.00	1.51
cerebrospinal fluid, donor2	10294-104G6	7.31	2.19	3.65	2.92	0.73	1.46	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	14.38	6.76	4.74	2.30	0.86	0.14	0.14	0.43	0.14
cervical cancer cell line:ME-180	10553-107I4	13.92	11.27	6.46	4.64	1.16	0.17	0.66	1.33	0.17
cervix, adult, pool1	10013-101C4	16.38	8.92	4.83	3.67	2.83	0.21	0.52	0.42	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	7.25	8.50	6.27	4.32	2.51	0.00	0.42	0.28	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	0.00	0.00	5.23	0.00	1.31	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	9.69	7.71	4.60	1.24	2.86	0.12	0.12	0.37	0.12
choriocarcinoma cell line:SCH	10785-110H2	10.60	3.08	3.70	1.36	0.62	0.00	0.12	0.25	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	4.03	3.79	7.35	0.71	2.85	0.00	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	3.42	7.69	4.27	3.42	1.42	0.00	0.28	0.57	0.00
chorionic membrane cells, donor2	12239-129G7	17.90	5.17	3.98	2.19	1.39	0.40	0.40	0.10	0.20
chorionic membrane cells, donor3	12240-129G8	8.79	8.79	6.59	6.04	1.10	0.00	0.00	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	8.08	2.02	1.01	1.01	2.02	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	9.60	6.72	2.69	1.54	1.34	0.77	0.19	1.34	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	6.76	3.59	2.53	1.27	0.84	0.63	0.63	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	27.48	10.79	7.96	1.28	2.05	1.03	0.26	0.77	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	31.69	9.68	6.53	3.14	3.39	0.73	0.48	0.73	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	27.89	11.40	4.89	0.81	1.43	0.20	0.00	1.02	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	19.43	7.07	3.24	0.88	0.00	1.18	0.59	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	7.82	7.82	2.09	3.13	0.26	0.26	0.52	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	30.40	2.97	2.29	0.23	1.14	0.46	0.00	0.00	0.23
clear cell carcinoma cell line:TEN	10636-108I6	11.62	4.34	2.26	2.08	1.39	1.21	0.00	0.69	0.00
colon carcinoma cell line:CACO-2	10513-107D9	15.01	2.56	1.83	1.10	0.73	0.00	0.00	0.37	0.00
colon carcinoma cell line:COLO-320	10420-106C6	24.71	5.70	7.22	1.52	3.80	0.00	0.76	0.76	0.76
colon, adult, donor1	10082-102B1	14.28	15.47	10.71	5.95	2.38	0.00	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	7.87	8.46	8.23	5.29	1.06	0.12	0.71	0.47	0.24
colon, fetal, donor1	10070-101I7	11.12	8.65	3.09	1.85	2.47	0.62	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	27.50	4.58	0.00	9.17	0.00	0.00	4.58	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	25.04	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	19.55	14.45	1.70	2.97	0.85	10.20	0.42	7.65	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	20.07	7.55	3.62	1.21	1.21	5.74	0.45	4.38	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	18.90	6.06	1.27	1.97	0.56	6.91	0.00	4.51	0.28
corpus callosum, adult, pool1	10042-101F6	26.31	6.08	11.61	8.51	4.64	0.00	1.00	0.22	0.66
cruciate ligament, donor2	10295-104G7	2.43	4.05	4.05	4.86	0.81	1.62	1.62	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	11.24	1.61	5.62	1.61	0.00	0.80	0.00	0.00	0.00
diencephalon, adult	10193-103E4	25.44	3.36	6.72	3.60	2.16	0.00	0.24	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	39.95	5.74	5.97	0.69	1.61	0.69	0.00	0.00	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	30.26	8.46	4.10	3.85	1.28	0.26	0.26	1.80	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	17.81	6.02	5.78	3.13	0.24	0.72	0.00	2.17	0.24
ductus deferens, adult	10196-103E7	6.98	14.95	6.98	4.98	1.50	1.50	0.50	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	8.64	8.64	11.52	1.44	4.32	0.00	0.00	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	8.09	8.09	9.56	2.21	2.94	0.74	2.21	0.00	0.00
dura mater, adult, donor1	10041-101F5	12.39	5.12	8.92	4.54	1.90	0.74	0.74	0.17	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	40.42	7.77	4.89	5.55	1.11	0.44	0.22	2.00	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	15.05	4.30	3.01	0.72	1.00	0.29	0.43	0.72	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	4.93	0.00	1.85	0.00	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	11.20	3.03	2.72	2.12	0.30	0.00	0.00	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	4.01	1.54	1.54	0.93	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	6.57	0.00	1.31	1.31	1.31	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	16.42	5.36	1.68	0.67	0.34	0.00	0.34	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	10.15	3.62	4.35	2.36	1.81	0.36	0.18	0.00	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	7.24	4.82	2.41	1.77	0.32	0.00	0.00	0.48	0.16
epidermoid carcinoma cell line:A431	10426-106D3	16.90	4.45	1.67	1.56	0.56	0.22	0.67	0.67	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	21.78	4.73	2.53	1.54	1.21	0.22	0.22	0.88	0.22
epididymis, adult	10197-103E8	15.07	11.09	6.70	4.60	1.88	1.05	0.42	1.05	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	6.74	1.95	6.21	1.24	0.89	0.00	0.71	0.00	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	5.51	0.79	2.36	1.57	0.00	0.00	0.39	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	32.50	15.46	13.89	4.06	3.28	0.39	0.79	0.52	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	23.72	9.65	10.24	2.76	2.95	0.39	0.49	0.30	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	29.80	13.33	9.52	2.46	2.58	0.34	0.22	0.56	0.56
esophagus, adult, pool1	10015-101C6	6.90	7.43	3.50	2.87	0.85	0.00	0.11	0.21	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	14.78	5.26	3.63	1.50	0.38	0.75	0.38	0.50	0.00
eye - muscle inferior rectus, donor1	10272-104E2	14.49	2.41	26.56	12.07	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	2.10	0.00	2.10	4.21	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	2.98	0.00	7.44	4.46	0.00	0.00	0.00	0.00	1.49
eye - muscle superior, donor2	10297-104G9	3.44	5.73	3.44	0.00	2.29	0.00	2.29	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	10.20	4.37	8.74	0.00	0.00	1.46	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	10.42	4.83	6.36	3.81	2.54	0.25	2.03	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	9.10	2.18	2.95	1.41	0.90	0.00	0.26	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	10.68	1.19	1.19	0.71	0.47	0.24	0.00	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	34.71	4.97	7.41	6.38	1.60	0.28	1.31	0.00	0.66
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	6.00	5.70	3.00	0.60	0.90	0.00	0.00	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	7.95	1.83	1.55	1.37	0.64	0.09	0.00	0.00	0.00
gall bladder, adult	10198-103E9	9.90	7.48	7.24	4.10	1.45	0.00	0.24	0.48	0.24
gamma delta positive T cells, donor1	11937-126A2	39.73	25.77	6.98	1.61	2.68	1.61	0.54	0.54	1.07
gamma delta positive T cells, donor2	11938-126A3	31.75	24.28	8.59	1.12	1.12	1.49	0.37	0.37	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	11.62	7.39	6.55	2.75	2.11	0.00	0.42	0.42	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	8.90	5.80	6.58	1.55	1.55	0.00	0.19	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	10.66	3.12	2.46	1.80	0.66	0.00	0.66	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	20.13	3.66	4.58	0.92	0.92	0.00	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	15.76	3.43	4.80	3.20	0.91	0.23	0.69	0.23	0.00
giant cell carcinoma cell line:LU65	10487-107B1	3.33	2.64	2.18	0.80	0.23	0.00	0.00	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	9.10	5.18	3.22	1.54	1.12	0.28	0.14	0.28	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	3.74	3.49	5.49	2.99	0.50	0.25	0.75	0.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	8.13	1.90	3.27	0.74	0.95	0.21	0.00	0.11	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	9.69	2.39	3.79	0.70	0.84	0.00	0.14	0.00	0.70
glioblastoma cell line:T98G	10485-107A8	14.68	2.87	2.98	2.21	0.77	0.33	0.00	0.33	0.22
glioma cell line:GI-1	10413-106B8	7.91	5.56	2.05	2.64	0.29	0.59	0.00	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	18.95	2.19	8.02	2.92	3.64	0.00	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	24.90	8.30	8.30	9.76	2.69	0.00	1.22	0.00	0.73
globus pallidus, adult, donor10258	10367-105F7	21.91	2.74	8.22	5.48	1.37	1.37	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	17.05	1.07	4.80	3.73	1.07	1.07	0.00	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	61.18	12.24	9.79	2.45	2.45	0.00	0.00	2.45	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	5.23	10.45	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	7.36	2.24	2.56	1.60	0.96	0.32	0.00	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	33.97	1.84	7.80	0.92	1.38	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	25.15	1.37	5.94	0.91	0.91	0.00	0.46	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	28.34	3.86	3.86	0.64	3.22	1.93	0.00	0.00	0.64
hIPS, biol_rep1	14380-156B6	31.62	2.87	5.75	0.00	1.44	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	36.35	1.37	4.80	0.69	1.37	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	28.69	1.10	5.52	2.21	2.21	0.00	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	12.93	4.60	1.72	0.57	0.29	2.01	0.00	2.30	0.29
heart - mitral valve, adult	10205-103F7	5.38	4.48	4.78	2.99	0.90	0.00	1.20	0.00	0.30
heart - pulmonic valve, adult	10206-103F8	7.06	3.40	2.88	2.35	1.83	0.00	0.26	0.00	0.26
heart - tricuspid valve, adult	10207-103F9	6.66	6.66	2.50	7.49	0.83	0.00	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	5.31	3.26	3.88	4.08	2.04	0.61	0.82	0.20	0.20
heart, adult, diseased, donor1	10051-101G6	5.11	3.41	7.24	4.26	3.83	0.00	1.70	0.00	0.43
heart, adult, pool1	10016-101C7	5.29	1.61	1.61	2.76	0.92	0.23	0.69	0.00	0.23
heart, fetal, pool1	10046-101G1	10.17	4.62	4.31	3.80	1.64	0.10	0.51	0.00	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	13.27	0.31	1.23	1.85	0.62	0.00	0.31	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	0.00	4.76	5.95	3.57	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	18.01	2.21	1.33	0.88	0.66	0.11	0.44	0.33	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	19.06	3.03	1.58	0.61	0.85	0.36	0.12	0.00	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	21.52	2.83	2.22	0.71	1.01	0.20	0.20	0.00	0.10
hepatoma cell line:Li-7	10484-107A7	20.69	3.11	3.78	3.67	1.11	0.44	0.33	0.89	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	13.27	1.91	2.01	0.30	1.01	0.00	0.10	0.40	0.00
hippocampus - adult, donor10196	10169-103B7	26.50	2.84	8.52	1.89	0.95	0.00	0.95	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	27.15	8.78	8.78	7.76	2.04	0.20	0.82	0.41	0.41
hippocampus, adult, donor10258	10374-105G5	27.39	2.49	12.45	1.99	2.49	0.00	0.00	0.00	1.99
hippocampus, newborn, donor10223	10363-105F3	26.44	3.52	1.76	4.93	0.70	1.06	0.35	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	21.36	6.71	3.05	0.61	1.22	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	15.51	4.32	2.75	2.16	1.18	0.00	0.00	0.20	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	20.82	2.54	2.54	1.27	0.51	0.51	0.25	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	18.61	5.07	5.64	1.69	2.82	0.00	0.00	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	26.08	10.07	5.42	0.52	4.39	0.77	0.26	0.77	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	24.67	5.31	7.97	1.14	3.04	0.00	0.76	0.00	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	15.47	4.67	6.42	2.04	1.46	0.00	1.46	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	19.82	4.09	5.17	1.72	1.51	0.00	0.43	0.65	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	21.27	2.09	6.26	1.25	0.42	0.83	1.25	0.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	11.84	2.60	3.55	0.24	2.60	0.47	0.00	0.00	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	22.82	3.70	4.82	1.29	1.93	0.48	0.16	0.16	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	13.47	2.02	8.08	2.02	0.67	0.00	0.00	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	24.88	2.66	1.25	0.94	0.47	0.16	0.16	0.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	23.58	3.93	1.97	0.49	0.98	0.00	0.49	0.98	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	13.96	2.62	6.98	2.62	3.49	0.00	0.00	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	21.95	8.97	9.74	0.57	3.82	0.76	1.15	0.19	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	22.68	9.16	9.59	0.44	6.54	0.44	0.44	0.44	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	12.49	6.50	9.00	1.50	3.00	0.00	0.50	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	19.03	3.20	4.52	1.32	1.88	0.38	0.38	0.57	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	21.83	3.64	7.73	1.36	2.27	0.91	0.45	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	15.98	3.45	5.64	2.82	2.51	0.31	0.31	0.31	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	20.58	5.23	6.04	1.47	1.47	0.33	0.82	0.16	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	24.10	3.77	5.52	1.74	1.74	0.00	0.58	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	18.53	3.59	5.38	2.69	2.39	0.30	0.30	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	21.43	5.36	1.85	0.55	1.29	0.55	0.18	0.18	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	21.40	5.42	1.43	0.29	2.00	0.00	0.29	0.57	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	17.56	4.49	3.67	0.41	1.63	0.82	0.41	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	21.48	3.87	7.39	1.06	2.82	0.35	0.00	1.06	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	19.32	2.22	5.38	0.32	3.17	0.00	0.32	0.32	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	13.32	6.36	8.47	1.21	2.12	0.00	0.30	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	13.45	2.07	6.72	1.55	0.52	0.00	0.00	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	15.28	2.66	4.65	1.33	1.33	0.66	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	16.42	2.31	4.62	1.54	0.51	0.51	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	14.83	1.53	3.32	0.00	0.26	0.51	0.77	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	20.45	1.51	3.03	0.76	0.00	0.76	0.00	0.76	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	11.43	2.69	4.37	1.01	1.34	0.00	0.67	0.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	17.63	4.11	2.90	1.21	1.21	0.24	0.24	0.24	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	13.37	5.79	4.46	0.45	2.67	0.89	0.00	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	24.39	7.32	1.95	0.49	0.98	0.00	0.00	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	14.36	5.50	7.95	1.53	2.75	0.00	0.31	0.31	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	22.77	6.51	22.77	6.51	3.25	0.00	0.00	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	13.24	5.30	8.27	0.66	3.97	0.33	0.66	0.99	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	18.61	3.83	8.76	0.55	0.55	0.00	0.55	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	14.84	1.81	6.88	1.09	0.72	0.00	0.00	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	13.17	3.20	4.98	1.42	2.14	0.36	0.36	0.71	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	22.67	2.39	4.77	0.00	1.19	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	17.88	1.08	5.55	1.49	1.35	0.27	0.41	0.14	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	12.93	2.69	2.16	1.35	1.35	0.27	0.00	0.27	0.27
immature langerhans cells, donor1	11904-125F5	4.84	8.48	5.09	0.97	0.00	21.07	0.00	0.73	0.00
immature langerhans cells, donor2	11905-125F6	8.71	15.05	7.13	4.75	3.17	7.92	0.00	3.96	0.00
insula, adult, pool1	10039-101F3	46.09	6.06	11.83	5.58	1.99	0.76	1.23	0.00	0.76
keratoacanthoma cell line:HKA-1	10791-110H8	8.78	4.88	3.90	0.33	0.65	0.00	0.00	0.33	0.00
kidney, adult, pool1	10017-101C8	11.61	5.71	5.91	4.11	0.90	0.20	0.70	0.10	0.40
kidney, fetal, pool1	10045-101F9	15.21	10.33	6.37	4.03	1.98	0.64	0.50	0.35	0.64
large cell lung carcinoma cell line:IA-LM	10509-107D5	16.90	2.98	1.56	0.43	0.85	0.00	0.14	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	14.93	1.38	3.46	2.90	0.83	0.83	0.41	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	12.11	2.20	2.20	3.12	0.55	0.73	0.18	0.37	0.00
left atrium, adult, donor1	10079-102A7	8.72	1.63	3.27	1.09	0.54	0.00	0.54	0.00	0.00
left ventricle, adult, donor1	10078-102A6	5.06	2.02	2.53	3.03	0.51	0.00	0.00	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	13.68	1.64	1.09	1.37	0.55	0.00	0.00	0.27	0.27
leiomyoma cell line:10964C	10569-108B2	8.98	2.87	3.23	2.16	0.36	0.36	0.00	0.72	0.36
leiomyoma cell line:15242A	10570-108B3	10.33	1.63	0.00	2.17	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	8.26	1.94	1.94	1.46	0.97	0.73	1.21	0.24	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	6.35	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	7.32	8.36	2.09	1.05	0.00	2.09	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	16.06	20.19	3.07	5.90	0.94	1.30	0.24	3.90	0.00
liposarcoma cell line:KMLS-1	10782-110G8	9.37	3.44	3.28	2.66	1.56	0.31	0.62	0.47	0.16
liposarcoma cell line:SW 872	10726-110A6	14.74	1.34	4.14	1.71	0.73	0.37	0.37	0.12	0.12
liver, adult, pool1	10018-101C9	4.38	8.59	8.75	2.92	0.97	0.32	0.65	0.16	0.00
liver, fetal, pool1	10086-102B5	9.41	22.58	4.70	3.76	2.82	0.00	0.00	1.88	0.94
locus coeruleus - adult, donor10196	10182-103D2	18.67	5.40	5.69	7.29	1.46	0.58	1.46	0.00	0.15
locus coeruleus, adult, donor10252	10165-103B3	22.15	8.86	7.20	8.12	2.58	0.37	0.92	0.18	0.55
locus coeruleus, adult, donor10258	10375-105G6	38.65	6.21	5.08	4.23	3.95	0.85	1.13	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	14.30	6.31	5.89	6.73	3.79	2.52	1.26	0.00	0.42
lung adenocarcinoma cell line:A549	10499-107C4	13.98	1.11	5.95	1.52	0.28	0.14	0.28	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	2.07	1.38	1.38	0.00	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	7.12	1.98	1.45	0.92	0.13	0.40	0.13	0.00	0.13
lung, adult, pool1	10019-101D1	11.34	9.10	2.72	3.90	0.95	0.12	0.47	0.12	0.47
lung, fetal, donor1	10068-101I5	10.27	8.85	13.70	3.71	3.14	0.86	0.57	0.29	0.29
lung, right lower lobe, adult, donor1	10075-102A3	18.79	13.29	6.87	0.92	2.75	0.46	1.37	0.92	0.00
lymph node, adult, donor1	10077-102A5	17.51	10.89	1.89	1.42	1.42	0.95	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	17.10	14.68	6.14	3.29	1.10	3.29	0.44	5.92	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	16.90	4.38	2.57	0.45	0.60	0.45	0.30	0.30	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	10.19	8.49	5.10	3.40	0.00	0.85	0.00	0.85	0.00
mature adipocyte, donor1	12231-129F8	12.43	4.44	4.44	3.55	1.33	0.44	0.44	0.00	1.78
mature adipocyte, donor2	12232-129F9	13.28	3.32	4.77	2.28	1.04	0.21	0.21	0.00	0.00
mature adipocyte, donor3	12233-129G1	8.77	3.32	4.74	2.37	0.47	0.24	0.47	0.24	0.24
mature adipocyte, donor4	12234-129G2	11.06	2.90	8.95	3.69	0.79	0.53	1.58	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	13.82	7.15	7.15	6.43	1.67	0.48	0.95	0.71	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	32.71	5.64	6.77	0.00	2.26	1.13	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	28.14	5.89	8.46	9.56	2.39	0.74	0.18	0.00	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	35.26	5.40	5.08	3.81	1.59	0.32	0.64	0.00	1.27
medial frontal gyrus, newborn, donor10223	10352-105E1	14.93	4.69	10.66	10.66	1.28	4.69	1.71	0.00	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	37.46	6.08	8.61	5.40	0.84	0.51	1.35	0.00	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	22.71	7.00	8.49	11.88	2.76	0.42	1.70	0.42	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	34.67	3.85	21.19	0.00	3.85	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	28.71	14.35	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	27.64	7.54	5.03	5.38	0.72	3.59	1.44	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	10.38	3.89	6.49	2.60	0.65	0.00	1.30	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	20.43	6.35	8.36	8.67	4.02	0.15	0.93	0.00	0.62
medulla oblongata, adult, pool1	10038-101F2	25.14	5.39	8.98	8.00	2.53	0.41	0.98	0.08	0.65
medulla oblongata, newborn, donor10223	10361-105F1	12.85	6.60	3.82	4.51	0.35	0.35	0.69	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	17.93	2.88	4.43	2.44	1.55	0.00	0.00	0.00	0.22
medulloblastoma cell line:ONS-76	10759-110E3	9.54	0.98	1.35	0.98	0.61	0.24	0.00	0.12	0.00
melanoma cell line:COLO 679	10514-107E1	5.03	2.73	2.44	4.02	0.86	0.14	0.29	0.00	0.00
melanoma cell line:G-361	10465-106H6	16.56	2.17	2.99	1.63	0.81	0.27	0.00	0.81	0.27
meningioma cell line:HKBMM	10691-109F7	9.77	1.99	0.90	1.81	0.54	0.00	0.00	0.36	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	19.39	4.41	4.41	0.88	0.00	0.00	0.00	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	14.78	5.70	6.22	1.56	0.52	0.26	0.78	0.00	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	12.74	2.92	2.92	1.23	1.23	0.31	0.00	0.15	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	15.27	2.54	3.45	1.64	0.73	0.00	0.36	0.00	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	8.28	4.56	4.14	1.66	1.66	0.00	0.00	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	8.85	2.95	3.23	1.26	1.12	0.14	0.00	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	6.35	2.89	3.66	1.73	1.35	0.00	0.19	0.39	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	9.72	2.78	1.39	4.16	0.00	0.00	0.00	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	8.41	2.40	3.09	0.86	0.86	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	8.51	3.22	3.22	1.50	1.15	0.23	0.00	0.12	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	9.55	2.39	3.71	1.46	1.06	0.13	0.13	0.13	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	9.18	2.30	3.11	0.68	0.14	0.00	0.14	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	9.82	1.99	1.56	1.14	0.71	0.28	0.14	0.43	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	5.60	2.63	2.63	1.32	1.98	0.00	0.33	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	11.35	2.91	3.32	0.42	0.42	0.00	0.28	0.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	17.45	1.75	2.44	0.35	0.00	0.00	0.35	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	10.62	1.43	1.43	1.02	1.63	0.20	0.00	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	6.47	2.88	5.03	1.80	0.72	0.00	0.36	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	8.48	3.72	2.90	0.21	1.24	0.21	0.21	0.00	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	6.16	4.56	1.82	0.68	0.23	0.23	0.00	0.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	13.43	3.36	5.45	0.84	0.42	0.84	0.42	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	11.66	3.14	3.59	1.20	0.60	0.30	0.15	0.15	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	11.12	3.85	2.80	1.05	0.96	0.00	0.35	0.09	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	12.89	2.58	2.58	1.47	1.47	0.00	0.74	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	12.88	2.86	2.00	2.58	0.29	0.29	1.14	0.57	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	9.26	1.68	4.21	1.68	0.84	0.84	0.42	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	13.24	2.74	3.20	0.91	0.91	0.00	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	8.95	2.30	4.35	1.28	1.02	0.26	0.26	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	10.47	1.83	2.09	1.31	2.36	0.26	0.26	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	11.40	3.08	3.70	1.23	1.23	0.31	0.62	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	9.88	3.06	4.24	0.94	1.18	0.47	0.24	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	9.82	5.42	2.71	0.68	2.37	0.34	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	12.58	2.75	1.57	1.18	0.39	0.39	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	10.19	3.24	2.78	0.93	1.39	0.46	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	17.02	1.73	5.48	1.73	1.44	0.00	0.87	0.00	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	10.71	3.35	5.13	1.34	0.67	0.67	0.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	12.02	2.64	3.61	0.96	1.68	0.00	0.72	0.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	13.93	2.20	2.20	2.93	0.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	10.07	4.36	2.69	1.01	1.34	0.00	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	7.78	3.28	2.87	0.82	0.82	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	6.87	3.44	4.73	2.58	1.72	0.00	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	0.00	0.00	5.47	0.00	0.00	5.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	6.82	2.60	2.60	2.27	1.30	0.32	0.65	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	8.73	4.36	1.45	1.45	0.00	0.00	0.00	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	9.06	3.20	2.67	2.13	0.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	7.36	0.00	2.45	0.00	1.64	0.00	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	7.00	3.50	3.11	1.17	0.78	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	2.10	2.10	2.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	8.94	0.99	7.95	0.00	1.99	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	0.00	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	8.30	1.78	4.74	0.59	0.59	0.59	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	12.18	4.87	1.22	1.22	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	10.13	3.17	3.17	1.90	0.00	0.00	0.63	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	8.62	3.10	1.38	0.69	1.38	0.00	0.69	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	8.60	0.00	4.30	0.00	0.00	0.00	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	0.00	0.00	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	5.30	2.44	0.81	2.04	0.41	0.00	0.41	1.22	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	9.53	3.97	4.77	2.38	2.38	0.00	0.79	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	10.02	5.90	1.77	4.13	0.59	0.00	0.00	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	9.04	3.12	1.87	1.87	0.62	0.00	0.31	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	4.01	10.69	5.35	1.34	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	3.55	1.18	2.37	2.37	1.18	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	10.27	2.57	0.00	0.00	2.57	0.00	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	11.70	3.44	2.07	3.44	2.75	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	7.92	0.99	4.45	2.97	0.49	0.00	0.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	4.49	1.12	1.12	0.00	0.00	1.12	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	4.45	1.91	3.82	0.64	0.00	0.00	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	6.45	2.01	5.24	2.01	0.40	0.00	0.40	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2.18	2.18	8.72	2.18	2.18	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	10.14	3.80	5.07	0.00	0.00	0.00	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	3.64	2.43	5.46	1.82	0.00	0.00	0.00	0.00	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	4.52	4.52	4.52	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	4.12	2.47	2.47	2.47	1.65	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	5.36	1.39	1.39	0.79	0.60	0.00	0.20	0.20	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	3.89	2.60	2.92	1.95	1.30	0.32	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	5.09	3.06	0.00	2.04	2.04	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	1.55	0.77	2.32	2.32	1.55	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	19.14	5.20	3.07	0.94	2.36	0.00	0.71	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	19.00	6.49	2.32	0.70	1.16	0.46	0.46	0.70	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	11.20	11.30	4.42	3.29	0.72	0.31	0.51	0.51	0.62
mesothelioma cell line:Mero-25	10850-111F4	11.12	6.58	3.18	2.50	0.45	0.23	0.45	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	18.09	2.44	4.40	0.00	0.73	0.24	0.00	0.73	0.24
mesothelioma cell line:Mero-48a	10852-111F6	11.51	5.54	5.09	3.76	0.22	0.22	0.00	0.22	0.22
mesothelioma cell line:Mero-82	10853-111F7	12.09	6.57	2.10	1.58	0.53	0.53	0.26	1.05	0.00
mesothelioma cell line:Mero-83	10854-111F8	11.23	5.96	4.09	3.57	0.51	0.85	0.00	0.68	0.34
mesothelioma cell line:Mero-84	10855-111F9	8.85	3.03	1.01	0.51	0.25	0.00	0.51	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	10.56	3.11	4.35	1.86	0.83	0.21	0.00	0.41	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	7.62	2.32	2.65	1.33	0.83	0.00	0.17	0.00	0.33
mesothelioma cell line:NCI-H226	10846-111E9	11.22	2.17	0.90	0.36	0.18	0.18	0.18	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	6.49	3.25	5.81	1.71	1.02	0.51	0.17	0.51	0.17
mesothelioma cell line:NCI-H28	10845-111E8	3.82	3.82	4.83	1.53	1.78	0.00	0.00	0.00	0.25
mesothelioma cell line:No36	10857-111G2	9.46	4.57	4.24	1.63	0.33	0.00	0.65	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	15.44	6.50	4.34	2.17	1.35	0.27	0.00	0.54	0.00
migratory langerhans cells, donor1	11901-125F2	12.47	12.47	6.33	2.30	1.15	19.96	0.19	0.38	0.19
migratory langerhans cells, donor2	11902-125F3	15.75	11.36	5.37	2.32	0.85	10.99	0.12	0.24	0.24
migratory langerhans cells, donor3	11903-125F4	17.59	12.03	7.18	1.79	1.62	5.38	0.36	0.18	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	18.94	3.92	2.29	0.98	1.31	0.65	0.33	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	19.29	1.91	2.54	0.42	1.06	0.00	0.00	0.21	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	10.14	1.15	1.38	2.76	0.23	0.00	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	19.03	6.28	4.38	3.04	0.76	2.47	0.57	7.42	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	17.00	11.83	5.91	2.22	8.13	0.00	0.55	0.18	0.74
myeloma cell line:PCM6	10474-106I6	11.66	11.86	7.12	2.97	0.99	0.40	0.00	0.59	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	15.22	1.52	0.51	1.01	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	15.69	3.53	4.32	1.77	2.16	0.20	0.39	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	3.90	2.12	2.12	1.34	1.34	0.00	0.22	0.22	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	2.35	2.28	3.38	1.47	0.66	0.00	0.15	0.07	0.15
nasal epithelial cells, donor2	12227-129F4	12.14	3.31	3.31	1.66	1.10	0.00	0.00	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	9.20	0.69	2.76	2.53	0.46	0.00	1.15	0.00	0.23
neuroblastoma cell line:NB-1	10539-107G8	15.34	3.74	2.25	1.68	0.94	0.19	0.37	0.19	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	29.95	3.80	5.90	1.90	1.48	0.00	0.42	0.21	0.42
neuroblastoma cell line:NH-12	10555-107I6	13.04	3.17	2.80	5.22	1.49	0.19	0.37	0.00	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	15.66	5.69	3.08	1.90	1.19	0.24	0.24	0.47	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	20.43	8.71	3.48	5.70	0.63	0.48	0.48	0.16	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	24.35	4.23	2.42	1.61	2.21	0.20	0.20	0.00	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	10.17	1.27	0.64	3.18	0.00	0.00	0.00	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	12.51	1.60	2.40	1.60	0.53	0.80	0.80	0.00	0.53
neutrophil PMN, donor1	12133-128D9	29.75	0.00	29.75	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	13.28	0.00	13.28	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	37.88	9.47	0.00	0.00	0.00	0.00	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	47.02	4.40	3.55	1.18	1.86	0.34	0.51	0.34	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	2.40	0.80	0.80	0.80	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	14.43	4.17	4.17	3.21	2.24	0.00	0.96	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	14.98	3.42	1.58	1.84	1.05	0.00	0.26	0.26	0.53
nucleus accumbens, adult, pool1	10037-101F1	37.50	4.69	7.69	4.78	1.97	0.47	1.03	0.00	0.56
occipital cortex - adult, donor10196	10172-103C1	14.42	4.12	6.18	2.06	4.12	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	20.66	6.44	12.34	9.39	2.68	0.27	1.88	0.00	0.54
occipital cortex, newborn, donor10223	10355-105E4	28.02	6.55	7.28	5.46	1.09	4.00	0.73	0.00	0.36
occipital lobe, adult, donor1	10076-102A4	26.24	3.41	11.55	3.41	2.10	0.26	1.57	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	21.88	3.43	7.29	2.15	2.15	0.86	0.86	0.00	0.43
occipital pole, adult, pool1	10036-101E9	38.71	5.76	10.49	5.20	2.21	0.24	2.13	0.08	1.02
olfactory region, adult	10195-103E6	27.70	3.06	6.69	3.82	3.06	0.38	0.57	0.19	0.38
optic nerve, donor1	10277-104E7	22.01	2.00	6.00	6.00	2.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	4.90	5.35	2.51	2.62	1.03	0.00	0.23	0.23	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	14.15	2.20	1.37	0.41	0.41	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	8.80	1.69	2.20	0.34	0.34	0.00	0.00	0.17	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	8.43	3.47	1.96	0.92	0.58	0.00	0.00	0.23	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	3.82	2.35	3.23	1.76	0.59	0.00	0.00	0.00	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	3.74	0.93	1.87	0.00	0.00	0.00	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	10.82	7.00	2.76	1.48	0.85	0.21	0.00	0.21	0.00
ovary, adult, pool1	10020-101D2	17.99	6.20	3.32	4.11	1.14	0.00	0.44	0.26	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	34.83	2.57	4.03	1.28	0.55	0.55	0.18	0.55	0.00
pancreas, adult, donor1	10049-101G4	6.58	6.58	6.58	4.70	1.88	0.00	0.94	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	7.27	13.14	5.59	3.07	1.96	0.00	0.56	0.84	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	12.44	6.98	5.79	3.75	0.85	0.17	0.51	0.00	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	18.71	4.97	4.80	2.32	0.83	0.00	0.66	0.17	0.50
paracentral gyrus, adult, pool1	10035-101E8	40.18	5.13	7.14	4.76	2.75	0.55	0.55	0.00	0.92
parietal cortex, adult, donor10258	10373-105G4	28.63	1.47	6.61	2.94	2.20	0.00	0.73	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	21.63	4.70	13.17	3.76	0.94	0.94	0.00	0.00	2.82
parietal lobe, adult, donor10252	10157-103A4	22.52	5.13	10.26	9.98	2.85	0.57	1.14	0.29	0.29
parietal lobe, adult, pool1	10034-101E7	35.78	7.31	7.75	4.67	2.64	0.18	1.32	0.00	0.70
parietal lobe, fetal, donor1	10072-101I9	34.91	3.88	2.91	0.97	1.94	0.00	1.94	0.00	1.94
parietal lobe, newborn, donor10223	10356-105E5	21.31	6.36	5.61	4.86	0.37	4.49	1.87	0.00	0.00
parotid gland, adult	10199-103F1	4.32	7.40	5.55	4.32	1.23	0.00	0.00	0.62	0.00
penis, adult	10200-103F2	12.35	3.76	4.30	3.22	2.15	0.00	1.07	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	15.99	4.46	3.35	4.65	1.30	0.00	0.56	0.19	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	11.22	2.19	3.06	0.58	0.44	0.29	0.29	0.00	0.29
pineal gland - adult, donor10196	10179-103C8	9.68	3.23	12.90	2.58	1.94	1.29	0.65	0.00	1.29
pineal gland, adult, donor10252	10160-103A7	17.77	8.88	10.66	4.74	1.78	0.00	1.78	0.59	0.59
pineal gland, adult, donor10258	10377-105G8	17.56	5.02	5.02	0.63	1.25	0.63	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	20.24	9.11	14.17	6.07	3.04	0.00	2.02	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	19.28	15.11	13.03	8.86	1.04	0.00	0.00	0.52	1.04
pituitary gland, adult, donor10258	10378-105G9	17.88	10.21	13.62	7.66	2.55	0.00	0.85	0.00	1.70
placenta, adult, pool1	10021-101D3	6.02	9.78	6.67	6.24	1.29	0.54	1.08	0.32	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	17.35	5.69	3.44	0.79	0.40	0.66	0.13	0.26	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	11.52	6.69	2.96	2.02	1.56	0.62	0.47	0.00	0.16
pons, adult, pool1	10033-101E6	26.51	5.08	6.63	4.65	2.93	0.52	0.86	0.26	0.69
postcentral gyrus, adult, pool1	10032-101E5	41.93	6.45	9.76	4.62	3.40	0.17	1.22	0.17	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	31.37	8.37	6.27	4.18	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	16.52	0.00	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	9.61	1.46	3.35	0.73	0.58	0.00	0.15	0.44	0.15
prostate cancer cell line:PC-3	10439-106E7	17.79	4.17	3.99	1.63	0.73	0.18	0.18	0.18	0.18
prostate, adult, pool1	10022-101D4	9.89	6.71	3.81	3.26	2.27	0.09	0.45	0.36	0.54
putamen, adult, donor10196	10176-103C5	57.60	5.43	8.97	3.30	1.89	0.71	1.18	0.24	0.00
putamen, adult, donor10252	10152-102I8	43.14	1.96	1.96	7.84	0.00	0.00	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	24.04	1.09	14.21	1.09	2.19	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	31.65	2.66	5.32	2.90	1.93	0.48	0.72	0.00	1.45
putamen, newborn, donor10223	10365-105F5	13.49	3.00	11.24	9.75	0.00	4.50	0.75	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	4.65	2.04	2.91	2.62	0.87	0.00	0.00	0.00	0.29
rectum, fetal, donor1	10067-101I4	27.82	5.56	4.17	0.00	1.39	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	9.54	1.91	2.12	1.27	0.64	0.42	0.00	0.00	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	12.84	5.38	0.41	1.24	1.24	0.00	0.41	0.00	0.00
retina, adult, pool1	10030-101E3	14.31	6.36	10.04	3.88	2.78	0.00	0.50	0.20	0.70
retinoblastoma cell line:Y79	10475-106I7	16.11	2.60	0.78	0.00	0.78	0.00	0.00	0.00	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	16.48	2.34	2.21	1.11	0.37	0.00	0.12	0.00	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	12.37	0.56	2.81	0.00	0.56	0.00	0.28	0.00	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	6.82	1.52	1.52	4.55	1.52	0.00	0.76	0.76	0.00
salivary acinar cells, donor1	11771-123I7	5.34	5.18	3.56	1.94	0.32	0.32	0.16	0.16	0.00
salivary acinar cells, donor2	11772-123I8	5.65	7.99	4.13	2.48	0.83	0.00	0.83	0.83	0.14
salivary acinar cells, donor3	11773-123I9	1.32	3.31	2.65	5.96	0.00	1.32	0.66	0.66	0.00
salivary gland, adult, pool1	10093-102C3	7.44	1.72	16.59	1.14	1.14	0.00	1.14	0.57	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	10.37	2.19	3.20	1.43	0.67	0.00	0.17	0.25	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	11.17	2.47	3.76	0.82	0.94	0.00	0.59	0.12	0.24
seminal vesicle, adult	10201-103F3	5.29	5.82	6.88	4.23	1.59	1.59	0.00	1.06	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	5.59	6.80	4.37	2.67	0.24	0.24	0.00	0.49	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	7.55	7.30	5.03	1.76	1.26	0.00	0.25	0.50	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	9.03	2.01	4.01	2.01	4.01	0.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	14.24	10.75	4.97	3.09	0.94	0.67	0.27	4.03	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	10.06	8.18	7.52	3.98	1.55	0.11	0.44	0.77	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	5.81	2.45	2.71	1.55	0.52	0.13	0.52	0.13	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	0.71	0.71	9.93	4.97	0.00	0.00	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	4.92	2.40	4.32	3.96	0.48	0.12	0.36	0.24	0.36
skeletal muscle, fetal, donor1	10066-101I3	6.03	2.01	4.02	3.02	1.01	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	6.79	20.36	6.79	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	9.47	2.52	3.16	7.57	1.26	0.63	0.63	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	24.35	5.34	5.00	1.67	2.33	0.00	0.33	0.00	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	16.39	7.56	5.36	5.99	1.89	0.32	0.63	0.32	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	26.41	2.70	5.98	5.40	3.28	0.77	1.16	0.96	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	7.09	4.94	2.80	0.33	1.32	0.00	0.33	0.99	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	15.76	4.02	7.24	3.22	2.90	0.16	0.64	0.00	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	15.91	6.76	8.06	3.92	1.96	0.22	0.44	0.22	0.44
small intestine, adult, pool1	10024-101D6	8.96	12.06	9.20	6.33	1.31	1.79	1.31	1.31	0.12
small intestine, fetal, donor1	10064-101I1	10.56	5.90	5.41	2.70	0.98	0.25	1.23	0.49	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	14.36	12.82	8.72	3.59	1.54	0.00	0.51	1.03	0.00
smooth muscle, adult, pool1	10048-101G3	18.87	3.36	6.46	3.88	1.29	0.26	0.78	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	3.48	2.68	3.75	2.68	0.00	0.00	0.27	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	16.29	4.59	6.65	11.01	1.61	0.00	1.38	0.00	0.46
spinal cord, adult, donor10252	10159-103A6	15.38	3.94	9.07	5.91	2.76	1.18	1.58	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	9.69	3.46	13.14	4.15	4.84	0.69	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	18.90	1.83	10.37	5.49	1.22	0.00	0.61	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	6.89	4.59	5.97	12.86	3.67	0.92	0.92	0.00	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	9.86	1.34	2.69	1.79	1.49	0.00	0.00	0.00	0.00
spleen, adult, pool1	10025-101D7	11.56	12.11	4.07	2.53	1.54	0.33	0.66	0.33	0.11
spleen, fetal, pool1	10044-101F8	12.16	14.22	6.20	5.56	3.34	0.72	0.48	0.56	0.64
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	14.18	7.25	2.38	0.72	0.72	1.86	0.00	1.04	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	7.41	3.42	2.47	0.95	0.19	0.38	0.00	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	11.53	2.80	6.64	2.45	0.70	0.00	0.00	0.35	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	9.77	2.35	1.56	2.35	0.39	0.78	0.00	0.78	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	9.12	2.93	3.26	1.58	0.34	0.11	0.11	0.23	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	11.01	2.54	1.27	0.42	0.00	0.00	0.00	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	21.15	7.19	3.81	2.54	1.27	0.42	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	18.16	3.20	6.41	1.07	1.07	1.07	1.07	0.00	1.07
submaxillary gland, adult	10202-103F4	10.25	5.70	3.99	5.70	2.28	0.00	0.57	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	15.58	12.46	6.02	8.10	3.53	0.21	0.42	0.21	0.21
substantia nigra, adult, donor10258	10371-105G2	18.10	3.62	8.79	4.66	3.62	0.00	1.55	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	9.89	1.41	7.07	4.95	1.41	0.71	0.71	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	22.24	3.67	6.19	1.15	0.92	0.46	0.23	0.00	0.23
temporal lobe, adult, pool1	10031-101E4	50.35	6.02	11.27	5.76	3.22	0.42	1.02	0.08	1.02
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	16.38	4.99	9.26	4.99	0.71	0.00	2.14	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	17.14	2.64	8.35	2.64	3.08	0.44	0.44	0.00	0.00
tenocyte, donor1	11763-123H8	15.71	5.93	3.14	1.75	1.40	0.35	0.00	0.35	0.35
tenocyte, donor2	11765-123I1	11.06	5.72	2.67	2.67	2.29	0.38	0.76	0.00	0.00
tenocyte, donor3	11768-123I4	9.27	12.60	5.93	1.48	2.97	0.00	0.00	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	31.78	3.06	4.76	0.68	2.72	0.51	0.34	0.17	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	12.79	1.70	2.77	1.39	1.23	0.31	0.31	0.31	0.00
teratocarcinoma cell line:PA-1	10807-111A6	17.36	1.70	1.86	0.46	1.24	0.15	0.31	0.15	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	12.31	7.74	2.67	1.02	0.76	0.13	0.76	0.63	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	18.91	7.56	3.40	2.65	1.51	0.00	0.00	0.00	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	12.11	8.62	1.96	1.96	0.98	0.55	0.33	0.11	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	4.89	3.58	1.63	0.65	0.98	0.65	0.33	0.98	0.33
testis, adult, pool1	10026-101D8	10.09	6.87	5.80	3.01	2.68	0.86	1.29	0.21	0.21
testis, adult, pool2	10096-102C6	8.12	3.16	11.73	4.06	2.26	0.00	0.00	0.45	0.45
thalamus - adult, donor10196	10168-103B6	22.08	2.21	5.52	8.83	1.10	1.10	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	17.03	8.13	8.60	9.53	2.66	0.16	1.09	0.16	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	27.71	1.54	23.09	4.62	3.08	0.00	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	17.95	3.29	4.28	2.64	1.32	0.16	0.49	0.16	0.33
thalamus, newborn, donor10223	10366-105F6	15.53	6.33	2.30	2.88	0.58	1.73	0.00	0.00	0.00
throat, adult	10209-103G2	7.74	6.74	5.24	3.50	1.50	0.75	1.25	0.25	1.00
throat, fetal, donor1	10061-101H7	18.28	3.96	6.70	2.13	2.44	0.00	1.22	0.00	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	29.81	3.38	1.99	0.20	0.40	0.00	0.40	0.20	0.20
thymus, adult, pool1	10027-101D9	26.84	13.42	7.46	2.29	2.88	0.50	0.99	0.80	0.60
thymus, fetal, pool1	10043-101F7	24.94	15.69	9.66	3.32	3.64	0.31	0.62	1.14	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	6.25	1.06	1.06	0.66	0.27	0.13	0.00	0.13	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	17.88	7.40	5.59	1.96	1.96	0.42	0.14	1.12	0.00
thyroid, adult, pool1	10028-101E1	14.93	9.98	6.63	4.67	1.40	0.09	0.65	0.19	0.09
thyroid, fetal, donor1	10060-101H6	15.03	6.86	7.91	2.64	2.11	1.05	0.79	0.00	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	15.40	3.08	9.24	3.08	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	5.12	5.58	3.95	3.02	0.93	0.00	0.00	0.23	0.00
tongue, fetal, donor1	10059-101H5	5.12	2.76	5.12	5.52	0.79	0.00	0.79	0.00	0.39
tonsil, adult, pool1	10047-101G2	16.53	12.42	5.91	3.81	1.70	0.70	0.50	0.60	0.30
trachea, adult, pool1	10029-101E2	8.34	6.71	4.25	2.78	1.47	0.08	0.41	0.57	0.33
trachea, fetal, donor1	10058-101H4	11.16	6.92	8.85	5.77	0.38	1.15	0.00	0.38	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	10.63	2.13	2.13	0.71	0.71	0.35	0.35	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	11.35	3.55	2.03	1.22	0.61	0.00	0.00	0.10	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	9.40	5.80	2.98	2.04	0.78	0.00	0.47	0.31	0.00
tridermal teratoma cell line:HGRT	10694-109G1	3.81	5.71	5.71	3.81	0.00	1.90	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	11.94	4.40	3.56	2.45	0.68	0.17	0.34	0.85	0.17
umbilical cord, fetal, donor1	10057-101H3	2.09	6.26	2.09	2.09	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	14.16	4.95	7.17	2.05	2.90	0.17	0.34	0.34	0.17
uterus, fetal, donor1	10055-101H1	13.82	2.05	4.61	6.14	1.02	0.51	0.00	0.51	0.00
vagina, adult	10204-103F6	6.46	7.11	3.23	10.99	0.65	0.00	1.29	0.00	0.00
vein, adult	10191-103E2	14.47	13.37	4.82	2.19	2.19	0.22	0.22	0.00	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	12.55	4.27	2.67	0.00	1.60	0.53	0.00	0.27	0.27